open/closed - Capital BlueCross
Transcription
open/closed - Capital BlueCross
FORMULARY (OPEN/CLOSED) 2016 Health care benefit programs issued or administered by Capital BlueCross and/or its subsidiaries, Capital Advantage Insurance Company,® Capital Advantage Assurance Company® and Keystone Health Plan® Central. Independent licensees of the BlueCross BlueShield Association. Communications issued by Capital BlueCross in its capacity as administrator of programs and provider relations for all companies. C34-835 (11/15) Capital BlueCross Formulary 2016 Effective July 1, 2016 THE FORMULARY ................................................................................................................................................................................................... 4 HOW TO USE THE FORMULARY........................................................................................................................................................................... 4 GENERIC DRUG SUBSTITUTION .......................................................................................................................................................................... 5 NON-PRESCRIPTION MEDICATION (OTC) POLICY* ........................................................................................................................................... 6 COMPOUND DRUG POLICY ................................................................................................................................................................................... 6 BENEFIT EXCLUSIONS / LIMITATIONS* ............................................................................................................................................................... 6 PRIOR AUTHORIZATION PROGRAM .................................................................................................................................................................... 6 QUANTITY LIMITATIONS........................................................................................................................................................................................ 7 MAINTENANCE DRUGS ......................................................................................................................................................................................... 7 INJECTABLE MEDICATION POLICY ..................................................................................................................................................................... 7 SPECIALTY MEDICATION PROVIDER: OUTPATIENT PRESCRIPTION DRUG BENEFIT................................................................................. 7 SPECIALTY DRUGS ................................................................................................................................................................................................ 8 LEGEND ................................................................................................................................................................................................................. 10 NOTICE................................................................................................................................................................................................................... 10 ANALGESICS......................................................................................................................................................................................................... 11 NSAIDs-M..................................................................................................................................................................................................... 11 NSAIDs, COMBINATIONS-M....................................................................................................................................................................... 11 NSAIDs, TOPICAL-M ................................................................................................................................................................................... 11 COX-2 INHIBITORS-M ................................................................................................................................................................................. 12 GOUT-M ....................................................................................................................................................................................................... 12 OPIOID ANALGESICS ................................................................................................................................................................................. 12 NON-OPIOID ANALGESICS ........................................................................................................................................................................ 14 ANTI-INFECTIVES ................................................................................................................................................................................................. 14 ANTIBACTERIALS ....................................................................................................................................................................................... 14 ANTIFUNGALS ............................................................................................................................................................................................ 16 ANTIMALARIALS ......................................................................................................................................................................................... 17 ANTIRETROVIRAL AGENTS-M .................................................................................................................................................................. 17 ANTITUBERCULAR AGENTS ..................................................................................................................................................................... 18 ANTIVIRALS................................................................................................................................................................................................. 18 MISCELLANEOUS ....................................................................................................................................................................................... 19 ANTINEOPLASTIC AGENTS ................................................................................................................................................................................ 20 ALKYLATING AGENTS ............................................................................................................................................................................... 20 ANTIMETABOLITES .................................................................................................................................................................................... 20 CYTOPROTECTIVE AGENTS..................................................................................................................................................................... 20 HORMONAL ANTINEOPLASTIC AGENTS ................................................................................................................................................. 20 IMMUNOMODULATORS ............................................................................................................................................................................. 21 KINASE INHIBITORS ................................................................................................................................................................................... 21 TOPOISOMERASE INHIBITORS ................................................................................................................................................................ 22 MISCELLANEOUS ....................................................................................................................................................................................... 22 CARDIOVASCULAR .............................................................................................................................................................................................. 22 ACE INHIBITORS-M .................................................................................................................................................................................... 22 ACE INHIBITOR/CALCIUM CHANNEL BLOCKER COMBINATIONS-M .................................................................................................... 23 ACE INHIBITOR/DIURETIC COMBINATIONS-M * ..................................................................................................................................... 23 ADRENOLYTICS, CENTRAL-M .................................................................................................................................................................. 23 ALDOSTERONE RECEPTOR ANTAGONISTS-M ...................................................................................................................................... 23 ALPHA BLOCKERS-M ................................................................................................................................................................................. 23 ANGIOTENSIN II RECEPTOR ANTAGONISTS/DIURETIC COMBINATIONS-M ...................................................................................... 24 ANGIOTENSIN II RECEPTOR ANTAGONIST/CALCIUM CHANNEL BLOCKER COMBINATIONS-M ..................................................... 24 ANGIOTENSIN II RECEPTOR ANTAGONIST/CALCIUM CHANNEL BLOCKER/DIURETIC COMBINATIONS-M ................................... 25 ANTIARRHYTHMICS-M ............................................................................................................................................................................... 25 ANTILIPEMICS-M ........................................................................................................................................................................................ 25 BETA-BLOCKERS-M ................................................................................................................................................................................... 27 BETA-BLOCKER/DIURETIC COMBINATIONS-M ...................................................................................................................................... 27 CALCIUM CHANNEL BLOCKERS-M .......................................................................................................................................................... 27 CALCIUM CHANNEL BLOCKER/ANTILIPEMIC COMBINATIONS-M ........................................................................................................ 28 1 DIGITALIS GLYCOSIDES-M ....................................................................................................................................................................... 28 DIRECT RENIN INHIBITORS/DIURETIC COMBINATIONS-M ................................................................................................................... 28 DIURETICS-M .............................................................................................................................................................................................. 28 NEPRILYSIN INHIBITOR/ANGIOTENSIN II RECEPTOR ANTAGONIST COMBINATIONS-M ................................................................. 29 NITRATES-M................................................................................................................................................................................................ 29 NITRATE/VASODILATOR COMBINATIONS-M .......................................................................................................................................... 29 PULMONARY ARTERIAL HYPERTENSION-M .......................................................................................................................................... 29 MISCELLANEOUS-M ................................................................................................................................................................................... 30 CENTRAL NERVOUS SYSTEM ............................................................................................................................................................................ 30 ANTIANXIETY .............................................................................................................................................................................................. 30 ANTICONVULSANTS-M .............................................................................................................................................................................. 30 ANTIDEMENTIA-M ...................................................................................................................................................................................... 32 ANTIDEPRESSANTS-M .............................................................................................................................................................................. 33 ANTIPARKINSONIAN AGENTS-M .............................................................................................................................................................. 35 ANTIPSYCHOTICS-M .................................................................................................................................................................................. 35 ATTENTION DEFICIT HYPERACTIVITY DISORDER ................................................................................................................................ 36 FIBROMYALGIA-M ...................................................................................................................................................................................... 37 HUNTINGTON'S DISEASE AGENTS-M ...................................................................................................................................................... 37 HYPNOTICS................................................................................................................................................................................................. 37 MIGRAINE .................................................................................................................................................................................................... 38 MOOD STABILIZERS-M .............................................................................................................................................................................. 39 MULTIPLE SCLEROSIS AGENTS-M .......................................................................................................................................................... 39 MUSCULOSKELETAL THERAPY AGENTS ............................................................................................................................................... 39 NARCOLEPSY ............................................................................................................................................................................................. 40 PSYCHOTHERAPEUTIC-MISCELLANEOUS ............................................................................................................................................. 40 RESTLESS LEGS SYNDROME .................................................................................................................................................................. 40 ENDOCRINE AND METABOLIC ........................................................................................................................................................................... 41 ANDROGENS .............................................................................................................................................................................................. 41 ANTIDIABETICS-M ...................................................................................................................................................................................... 41 ANTIOBESITY .............................................................................................................................................................................................. 45 CALCIUM RECEPTOR ANTAGONISTS-M ................................................................................................................................................. 45 CALCIUM REGULATORS-M ....................................................................................................................................................................... 45 CONTRACEPTIVES .................................................................................................................................................................................... 46 ENDOMETRIOSIS ....................................................................................................................................................................................... 49 ESTROGENS-M ........................................................................................................................................................................................... 49 ESTROGEN/PROGESTINS-M .................................................................................................................................................................... 50 ESTROGEN/SELECTIVE ESTROGEN RECEPTOR MODULATOR COMBINATIONS-M ......................................................................... 50 FERTILITY REGULATORS .......................................................................................................................................................................... 50 GLUCOCORTICOIDS .................................................................................................................................................................................. 51 GLUCOSE ELEVATING AGENTS ............................................................................................................................................................... 51 HUMAN GROWTH HORMONES ................................................................................................................................................................. 51 HYPERPARATHYROID TREATMENT, VITAMIN D ANALOGS-M ............................................................................................................. 51 INSULIN-LIKE GROWTH FACTOR ............................................................................................................................................................. 52 PHENYLKETONURIA TREATMENT AGENTS ........................................................................................................................................... 52 PHOSPHATE BINDER AGENTS-M............................................................................................................................................................. 52 PROGESTINS-M .......................................................................................................................................................................................... 52 SELECTIVE ESTROGEN RECEPTOR MODULATORS-M......................................................................................................................... 52 THYROID AGENTS-M ................................................................................................................................................................................. 52 VASOPRESSINS ......................................................................................................................................................................................... 53 MISCELLANEOUS ....................................................................................................................................................................................... 53 GASTROINTESTINAL ........................................................................................................................................................................................... 53 ANTIDIARRHEALS ...................................................................................................................................................................................... 53 ANTIEMETICS ............................................................................................................................................................................................. 53 ANTISPASMODICS ..................................................................................................................................................................................... 54 CHOLELITHOLYTICS-M .............................................................................................................................................................................. 54 H2 RECEPTOR ANTAGONISTS-M * ........................................................................................................................................................... 54 INFLAMMATORY BOWEL DISEASE .......................................................................................................................................................... 54 IRRITABLE BOWEL SYNDROME-M ........................................................................................................................................................... 55 LAXATIVES .................................................................................................................................................................................................. 55 OPIOID-INDUCED CONSTIPATION ........................................................................................................................................................... 55 PANCREATIC ENZYMES-M ........................................................................................................................................................................ 55 PROSTAGLANDINS-M ................................................................................................................................................................................ 55 PROTON PUMP INHIBITORS-M * .............................................................................................................................................................. 55 STEROIDS, RECTAL ................................................................................................................................................................................... 56 ULCER THERAPY COMBINATIONS .......................................................................................................................................................... 56 2 MISCELLANEOUS-M ................................................................................................................................................................................... 56 GENITOURINARY .................................................................................................................................................................................................. 56 BENIGN PROSTATIC HYPERPLASIA-M .................................................................................................................................................... 56 ERECTILE DYSFUNCTION ......................................................................................................................................................................... 57 URINARY ANTISPASMODICS-M ................................................................................................................................................................ 57 MISCELLANEOUS ....................................................................................................................................................................................... 58 HEMATOLOGIC ..................................................................................................................................................................................................... 58 ANTICOAGULANTS .................................................................................................................................................................................... 58 ANTIHEMOPHILIC AGENTS ....................................................................................................................................................................... 58 HEMATOPOIETIC GROWTH FACTORS .................................................................................................................................................... 59 HEMOSTATICS............................................................................................................................................................................................ 59 HEREDITARY ANGIOEDEMA AGENTS ..................................................................................................................................................... 59 IDIOPATHIC THROMBOCYTOPENIC PURPURA AGENTS-M.................................................................................................................. 60 IRON CHELATING AGENTS ....................................................................................................................................................................... 60 PLATELET AGGREGATION INHIBITORS-M .............................................................................................................................................. 60 PLATELET SYNTHESIS INHIBITORS-M .................................................................................................................................................... 60 STEM CELL MOBILIZERS ........................................................................................................................................................................... 60 MISCELLANEOUS-M ................................................................................................................................................................................... 60 IMMUNOLOGIC AGENTS...................................................................................................................................................................................... 60 BIOLOGIC DISEASE-MODIFYING AGENTS .............................................................................................................................................. 60 DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs)-M ............................................................................................................. 61 IMMUNE GLOBULINS ................................................................................................................................................................................. 61 IMMUNOMODULATORS-M ......................................................................................................................................................................... 61 IMMUNOSUPPRESSANTS-M ..................................................................................................................................................................... 61 NUTRITIONAL/SUPPLEMENTS............................................................................................................................................................................ 62 ELECTROLYTES ......................................................................................................................................................................................... 62 VITAMINS AND MINERALS ........................................................................................................................................................................ 62 RESPIRATORY ...................................................................................................................................................................................................... 63 ANAPHYLAXIS TREATMENT AGENTS ..................................................................................................................................................... 63 ANTICHOLINERGICS-M .............................................................................................................................................................................. 63 ANTICHOLINERGIC/BETA AGONIST COMBINATIONS-M ....................................................................................................................... 63 ANTIHISTAMINES, LOW SEDATING.......................................................................................................................................................... 63 ANTIHISTAMINES, NONSEDATING-M....................................................................................................................................................... 63 ANTIHISTAMINES, SEDATING ................................................................................................................................................................... 64 ANTIHISTAMINE/DECONGESTANT COMBINATIONS .............................................................................................................................. 64 ANTITUSSIVES............................................................................................................................................................................................ 64 ANTITUSSIVE COMBINATIONS ................................................................................................................................................................. 64 BETA AGONISTS-M .................................................................................................................................................................................... 64 CYSTIC FIBROSIS ...................................................................................................................................................................................... 65 LEUKOTRIENE MODIFIERS-M ................................................................................................................................................................... 65 MAST CELL STABILIZERS-M ..................................................................................................................................................................... 65 NASAL ANTIHISTAMINES .......................................................................................................................................................................... 65 NASAL ANTIHISTAMINE/STEROID COMBINATIONS ............................................................................................................................... 65 NASAL STEROIDS-M .................................................................................................................................................................................. 65 PHOSPHODIESTERASE-4 INHIBITORS .................................................................................................................................................... 66 PULMONARY FIBROSIS AGENTS ............................................................................................................................................................. 66 STEROID/BETA AGONIST COMBINATIONS-M ......................................................................................................................................... 66 STEROID INHALANTS-M ............................................................................................................................................................................ 66 XANTHINES-M ............................................................................................................................................................................................. 67 TOPICAL ................................................................................................................................................................................................................ 67 DERMATOLOGY.......................................................................................................................................................................................... 67 MOUTH/THROAT/DENTAL AGENTS ......................................................................................................................................................... 71 OPHTHALMIC .............................................................................................................................................................................................. 72 OTIC ............................................................................................................................................................................................................. 74 WEBSITES ............................................................................................................................................................................................................. 75 INDEX ..................................................................................................................................................................................................................... 77 3 THE FORMULARY Capital BlueCross (Capital) has created the Formulary to give members access to quality, affordable medications and to provide physicians with a reference list of preferred medications for cost-effective prescribing. The Formulary represents the cornerstone of drug therapy quality assurance and cost containment efforts. The Capital Formulary was developed and is maintained by the Capital BlueCross Pharmacy and Therapeutics (P&T) Committee. This committee, composed of practicing physicians from various medical specialties, practicing pharmacists, and other health care providers, reviews medications in all therapeutic categories based on safety and effectiveness and designates the most effective agent(s) in each class. Formulary development and maintenance is a dynamic process. The P&T Committee will regularly review new and existing medications to ensure the Formulary remains responsive to the needs of our members and providers. A provider may request a reconsideration of tier status for a medication on the Capital Formulary by completing a Formulary Status Reconsiderations Form or by writing a letter indicating the significant advantages of the specific drug product and mailing it to the address below: Pharmacy Services Capital BlueCross P&T Committee P.O. Box 773735 Harrisburg, PA 17177-3735 The P&T Committee will review drug-specific requests and communicate the results of the review to the requesting provider. Patient-specific requests need to follow the Professional Provider dispute and appeal process. HOW TO USE THE FORMULARY The Formulary lists the most commonly prescribed medications by therapeutic class. Medications listed in bold lower case print are generic medications, and medications listed in all UPPER CASE PRINT are brand-name medications. For each drug listed, it is indicated whether that drug falls in the Generic Preferred category, Generic Non-Preferred category, Brand Preferred category or Brand Non-Preferred category. These categories are defined as follows: Generic Preferred (GP) and Generic Non-Preferred (GNP): Drugs that contain the same active ingredient(s) as their corresponding brand-name drug and have been approved by the U.S. Food and Drug Administration (FDA) for therapeutic equivalency to their brand-name product. Please note that not all strengths and formulations of generic drugs have the same tier status. Brand Preferred (BP): Drugs that have been reviewed by the Capital BlueCross Pharmacy & Therapeutics Committee and found to have therapeutic advantage or overall value over nonpreferred brands, factoring safety, efficacy, and cost. Brand Non-Preferred (BNP): Drugs that have been reviewed by the Capital BlueCross Pharmacy & Therapeutics Committee and found not to have significant therapeutic advantage or overall value over alternative generics, preferred brands or over-the-counter medications. To help maximize the pharmacy benefit, preferred formulary alternatives, where applicable, are provided. Please note that the information provided is not intended to substitute for the physician's independent medical judgment based on the member's specific needs. The information contained in this document is current at the time of printing, is not all encompassing and is subject to change. 4 The Formulary serves as a reference guide suitable for various formulary systems, ranging from an open incentive four-tier formulary to a closed formulary. The open formulary provides access to all covered products, whether they are designated generic preferred (tier 1), generic non-preferred (tier 2), brand preferred (tier 3), or brand non-preferred (tier 4). Under this formulary system, members are encouraged to use generic or preferred brand drugs which typically carry a lower copayment/coinsurance than non-preferred brand drugs. (Please note that all plans do not include a two-tier generic benefit with a different copayment/coinsurance for each generic tier. For plans that do not have a two-tier generic benefit, the generic copayment/coinsurance will be applied to both generic preferred and generic nonpreferred drugs. Please also note that for specialty medications, the specialty generic cost share, when applicable, will apply to both generic preferred and generic non-preferred specialty medications.) The closed formulary provides access to only products that are on the formulary (generic preferred, generic non-preferred and brand preferred drugs)*. Under this formulary, non-formulary drugs (brand non-preferred drugs) are not covered unless approved via a Non-Formulary Consideration Process. The provider or member may initiate a request that coverage be granted when medically necessary. The Non-Formulary Consideration Process may require the trial and failure of two (2) formulary alternatives (if two are available) prior to approval of the non-formulary medication. Approvals will be member- and drug-specific. Each unique non-formulary drug exception must be reviewed and approved separately. *Select brand non-preferred drugs may be covered due to Affordable Care Act mandates under Health Care Reform. As determined by the member’s benefit plan, the member may share more of the cost for brand-name drugs, especially those designated as non-preferred brands. Despite being listed in the formulary, please note that some drugs are excluded by benefit design and therefore are not covered (see Benefit Exclusions/Limitations below). Newly-released brand-name drugs are not covered until the P&T Committee reviews the medication’s safety and efficacy profile. Brand-name drugs that have an available generic equivalent, deemed suitable for substitution by the P&T Committee, are placed in the non-preferred brand category. The Formulary applies only to prescription medications dispensed in outpatient pharmacies. The Formulary does not apply to inpatient medications or to medications obtained from and/or administered by a physician or a home health agency. While Capital BlueCross strives to provide prompt notice of changes and updates, the Formulary, as well as the pharmacy clinical programs (such as prior authorization, quantity level limits, etc.), are subject to change. Please visit our website at www.capbluecross.com for current information. If preferred, contact our pharmacy benefit manager via phone at the number listed below. CVS Caremark® 1-800-585-5794 (for provider and member inquires) On behalf of Capital BlueCross, CVS Caremark assists in the administration of our prescription drug program. CVS Caremark is an independent pharmacy benefit manager. GENERIC DRUG SUBSTITUTION Generic drug substitution is encouraged if the FDA has determined the generic drug is bioequivalent to the brand-name product. Depending on the member's prescription drug benefit plan, one of the following generic substitution policies will be applied. The member's financial responsibility for a brand-name medication when a generic equivalent is available will vary depending on the member's generic substitution program. For members with mandatory generic substitution, if the physician indicates "Dispense As Written" (DAW) or if a member requests a brand-name product when a generic is available, the member is responsible for the cost difference between the brand-name medication and its generic cost (ancillary charge) in addition to the member's applicable brand copayment/coinsurance, up to the original cost of the brand-name medication. 5 For members with restricted generic substitution, if a member requests a brand-name product when a generic is available, the member is responsible for the cost difference between the brandname medication and its generic cost (ancillary charge) in addition to the member's applicable brand copayment/coinsurance, up to the original cost of the brand-name medication. If the physician indicates DAW, then the member pays the applicable copayment/coinsurance for the brand product and is not required to pay the ancillary charge. For members with voluntary generic substitution, the member will pay only the applicable copayment/coinsurance for the brand product. Capital encourages generic substitution, when possible and appropriate, to help reduce the member's out-ofpocket expense, plus help contain the overall cost of the prescription drug benefit. NON-PRESCRIPTION MEDICATION (OTC) POLICY* Select Over-The-Counter (OTC) products may be covered as determined by Capital BlueCross or if mandated by the Patient Protection and Affordable Care Act (PPACA). If a prescription drug has an available OTC equivalent, the prescription drug will not be covered. Physicians and pharmacists should guide and refer members to the OTC equivalent product, when appropriate. *As mandated by PPACA, select Over-The-Counter medications may be covered at $0 cost share for members with individual coverage or members of a non-grandfathered group health plan. Please consult your employer for questions relating to grandfathered status. COMPOUND DRUG POLICY Prescribed compound drug products are considered Brand Non-Preferred (BNP) and require prior authorization. BENEFIT EXCLUSIONS / LIMITATIONS* Depending on the member's pharmacy benefit plan, some medications listed may not be covered for individual members based on benefit design purchased by the member or employer group. Examples of contractual exclusions include, but are not limited to: Appetite suppressants (weight loss) Infertility medications Drugs used for cosmetic purposes (wrinkles, hair loss, etc.) Erectile dysfunction medications Smoking cessation products Contraceptives Non self-administered injectable drugs Allergy serums Experimental and investigational (including off-label use) use Some types of vitamins (non-prenatal) Products with OTC equivalents Some members' employer groups may choose to purchase additional coverage for these drug classes, while other employer groups may choose to exclude these drug classes from their Capital BlueCross health benefit plan. *As mandated by PPACA, select medications in these drug classes may be covered at $0 cost share for members with individual coverage or members of a non-grandfathered group health plan. Please consult your employer for questions relating to grandfathered status. PRIOR AUTHORIZATION PROGRAM Most pharmacy benefit plans include the prior authorization program. Prior authorization helps encourage appropriate and cost-effective use of certain drugs by allowing coverage only after clinical criteria are met. All clinical criteria are regularly reviewed and approved by the P&T Committee. 6 Drugs requiring prior authorization are subject to change. Please always visit our website (www.capbluecross.com) for the most up-to-date information on drugs requiring prior authorization. Drugs requiring prior authorization are designated in the Formulary by “PAR” (Prior Authorization Required) after the drug name. These drugs require prior authorization before members can obtain them as a covered benefit. For some drugs, part of the criteria may be automated (Enhanced Prior Authorization or EPA) to encourage first-line agents before second-line agents are utilized. If automated criteria are not met, then prior authorization is required by the physician (or representative) or pharmacist by calling / faxing the request with supporting clinical information to the pharmacy benefit manager at: CVS Caremark Prior Authorization Department Telephone: 1-800-294-5979 Fax: 1-888-836-0730 QUANTITY LIMITATIONS Some drug products may be subject to quantity limitations based on FDA-recommended doses or adopted clinical guidelines. These drugs are designated in the Formulary by “QLL” (Quantity Level Limits) after the drug name. The purpose of these maximum quantity limits is to ensure the proper billing of products and encourage the use of therapeutically indicated drug regimens. Quantity limitations are subject to change. Please check your provider manual or the on-line formulary at our website (www.capbluecross.com) for the most up-to-date information on drugs that are part of this program. If a quantity of medication exceeding the limit is required, the physician (or representative) or pharmacist should call / fax the request with supporting clinical information to the pharmacy benefit manager at: CVS Caremark Prior Authorization Department Telephone: 1-800-294-5979 Fax: 1-888-836-0730 MAINTENANCE DRUGS Maintenance drugs are prescriptions commonly used to treat conditions that are considered chronic or longterm. These conditions usually require regular, daily use of medicines. Examples of maintenance drugs are those used to treat high blood pressure, heart disease and diabetes. INJECTABLE MEDICATION POLICY Self-administered pharmacy injectable medications are usually covered under the Capital BlueCross prescription drug benefit. Injectable medications that are not routinely self-administered are not covered under the prescription drug benefit, but may be covered under the member’s medical benefit. Procurement of select medical injectable medications may be available from ACRO Pharmaceuticals (by calling 1-800-906-7798 or faxing 1-877-381-3806), Capital BlueCross’ specialty medical injectable provider, which will assist with distribution and billing of these medications. On behalf of Capital BlueCross, ACRO Pharmaceutical Services LLC assists in the administration of physician-administered specialty medications. ACRO Pharmaceutical Services is an independent company. SPECIALTY MEDICATION PROVIDER: OUTPATIENT PRESCRIPTION DRUG BENEFIT Specialty oral medications and self-administered injectable medications are available through Accredo® under the Capital BlueCross outpatient prescription drug benefit. Members or providers can call 1-877-595-3707 or fax 1-888-773-7386 to receive more information on starting service. The following medications are available through Accredo. (This list is current as of the printing of this formulary but is subject to change.) On behalf of Capital BlueCross, Accredo Health Group, Inc. assists in the delivery of specialty medications directly to our Members. Accredo Health Group, Inc. is an independent company. Note: Bolded products on the Specialty Drugs list below are available exclusively from Accredo. Products denoted with an asterisk (*) on the Specialty Drugs list below may also be obtained at network pharmacies. 7 Specialty Drugs ACTEMRA* PAR, QLL ACTHAR HP* PAR ACTIMMUNE* ADCIRCA* PAR ADEMPAS* PAR ADVATE* AFINITOR* ALECENSA* PAR ALPHANATE* ALPHANINE SD* ALPROLIX* AMPYRA* PAR, QLL APOKYN* ARANESP PAR ARCALYST* AUBAGIO* PAR AVONEX BARACLUDE* BEBULIN* BEBULIN VH* BENEFIX* BERINERT* BETASERON BETHKIS* BEXAROTENE BOSULIF* PAR BRAVELLE CAPECITABINE CAPRELSA* CARBAGLU* CERDELGA* PAR CETROTIDE CHOLBAM* PAR CHORIONIC GONADOTROPIN* CIMZIA* PAR, QLL COAGADEX* COMETRIQ* PAR COPAXONE COPEGUS CORIFACT* COSENTYX* PAR COTELLIC* PAR CYSTADANE* CYSTAGON* PAR CYSTARAN* DAKLINZA* PAR EGRIFTA* PAR ELIGARD* ELOCTATE* ENBREL PAR, QLL ENTECAVIR* EPOGEN PAR ERIVEDGE* PAR ESBRIET* PAR EXJADE* PAR EXTAVIA* EPA FARYDAK* PAR FEIBA NF* FEIBA VH* FERRIPROX* PAR FIRAZYR* FIRMAGON* FOLLISTIM AQ FORTEO PAR FUZEON GANIRELIX GATTEX* PAR GENOTROPIN PAR GILENYA* GILOTRIF* PAR GLATIRAMER GLEEVEC* GONAL-F GONAL-RFF GRANIX* HARVONI PAR HETLIOZ PAR HELIXATE FS* HEMOFIL M* HIZENTRA* HUMATE-P HUMATROPE PAR HUMIRA PAR, QLL HYCAMTIN* HYQVIA* IBRANCE* PAR ICLUSIG* PAR IDELVION* IMATINIB MESYLATE* IMBRUVICA* PAR INCRELEX PAR INLYTA* PAR INTRON A IRESSA* IXINITY* JADENU* PAR JAKAFI* PAR JUXTAPID* PAR KALYDECO* PAR KINERET PAR, QLL KOATE-DVI* KOGENATE FS* KORLYM* PAR KUVAN* KYNAMRO PAR LENVIMA* PAR LETAIRIS* PAR LEUKINE LEUPROLIDE ACETATE LONSURF* PAR LUPANETA* LUPRON DEPOT LYNPARZA* PAR MATULANE* 8 MEKINIST* PAR MENOPUR* MIRCERA* MODERIBA* MONOCLATE-P* MONONINE* MOZOBIL* PAR MYALEPT* PAR NATPARA* PAR NEULASTA NEUPOGEN NEXAVAR NINLARO* PAR NORDITROPIN PAR NORTHERA* PAR NOVAREL NOVOEIGHT* NOVOSEVEN RT* NUTROPIN AQ PAR NUWIQ* OCTREOTIDE* ODOMZO* PAR OFEV PAR OLYSIO* PAR OMNITROPE* PAR OPSUMIT* PAR ORENCIA 125 mg/mL* PAR, QLL ORENITRAM PAR ORFADIN* ORKAMBI* PAR OTEZLA PAR OTREXUP* OVIDREL PEGASYS PEGINTRON EPA PEGINTRON REDIPEN EPA PLEGRIDY* POMALYST* PAR PRALUENT* PAR PREGNYL PROCRIT PAR PROCYSBI* PAR PROFILNINE SD* PROMACTA* PULMOZYME* RASUVO* RAVICTI* REBETOL REBIF EPA RECOMBINATE* REMODULIN* REPATHA* PAR REPRONEX REVATIO* PAR REVLIMID RIBAPAK* RIBASPHERE* RIBAVIRIN RIXUBIS* SABRIL* SAIZEN PAR SAMSCA SANDOSTATIN* SANDOSTATIN LAR* SENSIPAR* SEROSTIM PAR SIGNIFOR* PAR SILDENAFIL* PAR SIMPONI* PAR, QLL SOMATULINE* PAR SOMAVERT* SOVALDI* PAR SPRYCEL STELARA* PAR, QLL STIVARGA* PAR STRENSIQ* PAR SUTENT SYLATRON* PAR SYNAREL* TAFINLAR* PAR TAGRISSO* PAR TALTZ* PAR TARCEVA PAR TARGRETIN TASIGNA TECFIDERA TECHNIVIE* PAR TEMODAR TEMOZOLOMIDE TETRABENAZINE* PAR THALOMID TIKOSYN* TOBI* TOBRAMYCIN INHALATION SOLN* TRACLEER* PAR TRETTEN* TYKERB TYVASO* PAR UPTRAVI* PAR VALCHLOR* VELTASSA* PAR VENTAVIS* PAR VIEKIRA PAK* PAR VOTRIENT* WILATE* XALKORI* XELJANZ* PAR XELJANZ XR* PAR XELODA XENAZINE* PAR XTANDI* PAR XURIDEN* PAR XYNTHA* ZARXIO* ZELBORAF* ZEPATIER PAR ZOLINZA ZOMACTON* PAR 9 ZORBTIVE PAR ZYDELIG* PAR ZYKADIA PAR ZYTIGA* PAR LEGEND AL BNP BP EPA GP and GNP M OTC PAR PHC QLL SRx boldface delayed-rel ext-rel Age Limitations apply. Brand Non-Preferred: Drugs that have been reviewed by the Capital BlueCross Pharmacy & Therapeutics Committee and found not to have significant therapeutic advantage or overall value over alternative generics, preferred brands or over-thecounter medications. Brand Preferred: Drugs that have been reviewed by the Capital BlueCross Pharmacy & Therapeutics Committee and found to have therapeutic advantage or overall value over non-preferred brands, factoring safety, efficacy, and cost. Enhanced Prior Authorization applies. Generic Preferred and Generic Non-Preferred: Drugs that contain the same active ingredient(s) as their corresponding brand-name drug and have been approved by the Food and Drug Administration (FDA) for therapeutic equivalency to their brandname product. Maintenance Drugs: ‘M’ located after the drug class name indicates the drugs in the class are generally considered maintenance drugs. Over-The-Counter medication. Prior Authorization Required. Preventive Health Care: Drugs that have been reviewed by the Capital BlueCross Pharmacy & Therapeutics Committee and are mandated by the Patient Protection and Affordable Care Act (PPACA) to have $0 cost share for members with individual coverage or members of a group health plan that is not "grandfathered" under PPACA. Please consult your employer for questions relating to grandfathered status. Quantity Level Limits apply. Specialty Drug available from Accredo. Indicates generic; boldface may not apply to every strength or dosage form under the listed generic name. Delayed-release (also known as enteric-coated), refer to the reference brand listed for clarification. Extended-release (also known as sustained-release), refer to the reference brand listed for clarification. NOTICE The information provided is intended to establish a guideline to help promote Formulary compliance, but it is in no way to be considered all encompassing. The Formulary is also in no way meant to interfere with the physician's independent medical judgment based on specific needs of the patient. The information contained herein is current at the time of printing and may be subject to change. Members should refer to their Certificate of Coverage for specific terms, conditions, exclusions and limitations relating to coverage. The information contained in this document is proprietary. The information may not be copied in whole or in part without written permission. ©2016. All rights reserved. This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers. Capital BlueCross and CVS Caremark do not operate the websites/organizations listed below, nor are they responsible for the availability or reliability of the websites' content. These listings do not imply or constitute an endorsement, sponsorship or recommendation by Capital BlueCross or CVS Caremark. 10 ANALGESICS Practice guidelines of pain management are available at: http://www.asahq.org NSAIDs-M ibuprofen meloxicam tabs naproxen EC tabs 375 mg naproxen sodium tabs 275 mg naproxen tabs sulindac tabs 150 mg diclofenac potassium diclofenac sodium delayed-rel diflunisal etodolac indomethacin ketoprofen meloxicam susp nabumetone naproxen EC tabs 500 mg naproxen sodium ext-rel naproxen sodium tabs 550 mg naproxen susp oxaprozin piroxicam sulindac tabs 200 mg ZORVOLEX MOBIC NAPRELAN ZIPSOR PAR PAR PAR GP GP GP GP GP GP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP BP BNP BNP BNP PREFERRED ALTERNATIVES MOBIC: meloxicam NAPRELAN: naproxen sodium ext-rel ZIPSOR: diclofenac potassium, diclofenac sodium, ibuprofen, naproxen, naproxen EC, naproxen sodium NSAIDs, COMBINATIONS-M PAR PAR DUEXIS VIMOVO BNP BNP PREFERRED ALTERNATIVES DUEXIS: diclofenac potassium, diclofenac sodium, ibuprofen, naproxen, naproxen EC, naproxen sodium VIMOVO: diclofenac potassium, diclofenac sodium, ibuprofen, naproxen, naproxen EC, naproxen sodium NSAIDs, TOPICAL-M EPA PAR diclofenac sodium soln FLECTOR PENNSAID GNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 11 PAR REXAPHENAC BNP PREFERRED ALTERNATIVES FLECTOR: meloxicam, naproxen PENNSAID: diclofenac sodium soln REXAPHENAC: diclofenac sodium soln COX-2 INHIBITORS-M EPA EPA celecoxib CELEBREX GNP BNP PREFERRED ALTERNATIVES CELEBREX: celecoxib GOUT-M allopurinol colchicine probenecid COLCRYS ULORIC EPA GP GNP GNP BNP BNP PREFERRED ALTERNATIVES COLCRYS: colchicine ULORIC: allopurinol OPIOID ANALGESICS Practice Guidelines for Cancer Pain Management (includes WHO analgesic ladder) are available at: http://www.asahq.org http://www.nccn.org Opioid guidelines in the management of chronic non-malignant pain are available at: http://www.asipp.org/Guidelines.htm QLL QLL QLL QLL QLL QLL QLL EPA, QLL QLL QLL QLL QLL QLL codeine sulfate tabs 15 mg codeine/acetaminophen soln codeine/acetaminophen tabs 300/15 mg, 300/30 mg hydrocodone/acetaminophen tabs 5/325 mg hydromorphone tabs 2 mg meperidine tabs 50 mg morphine sulfate soln 20 mg/5 mL tramadol butorphanol nasal spray codeine/acetaminophen tabs 300/60 mg fentanyl patches fentanyl transmucosal lozenges hydrocodone/acetaminophen caps hydrocodone/acetaminophen soln 7.5/325 mg/15 mL hydrocodone/acetaminophen tabs 2.5/325 mg, 5/300 mg, 7.5/300 mg, 7.5/325 mg, 10/300 mg, 10/325 mg hydrocodone/ibuprofen hydromorphone ext-rel hydromorphone soln, supp GP GP GP GP GP GP GP GP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 12 QLL QLL QLL QLL QLL QLL QLL EPA, QLL EPA, QLL QLL QLL EPA, QLL QLL EPA, QLL QLL QLL QLL QLL QLL QLL EPA, QLL QLL QLL QLL QLL QLL hydromorphone tabs 4 mg, 8 mg meperidine soln meperidine tabs 100 mg morphine sulfate ext-rel morphine sulfate soln 20 mg/mL, 10 mg/5 mL morphine sulfate tabs oxycodone oxycodone/acetaminophen tabs oxycodone/aspirin oxycodone/ibuprofen oxymorphone tramadol ext-rel tramadol/acetaminophen ABSTRAL ACTIQ BUTRANS DURAGESIC FENTORA KADIAN LAZANDA MS CONTIN NUCYNTA NUCYNTA ER OPANA OPANA ER OXYCONTIN SUBSYS ULTRACET ULTRAM ULTRAM ER XARTEMIS XR ZOHYDRO ER GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ACTIQ: fentanyl transmucosal lozenges DURAGESIC: fentanyl patches FENTORA: fentanyl transmucosal lozenges KADIAN: morphine sulfate ext-rel LAZANDA: fentanyl transmucosal lozenges MS CONTIN: morphine sulfate ext-rel NUCYNTA: oxycodone NUCYNTA ER: morphine sulfate ext-rel OPANA: morphine sulfate ext-rel, oxymorphone OPANA ER: morphine sulfate ext-rel OXYCONTIN: oxycodone, morphine sulfate ext-rel SUBSYS: fentanyl transmucosal lozenges ULTRACET: tramadol/acetaminophen ULTRAM: tramadol ULTRAM ER: tramadol ext-rel GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 13 XARTEMIS XR: oxycodone, oxycodone/acetaminophen ZOHYDRO ER: morphine sulfate ext-rel NON-OPIOID ANALGESICS butalbital/acetaminophen/caffeine caps, tabs butalbital/aspirin/caffeine caps, tabs GNP GNP ANTI-INFECTIVES Hepatitis: CDC recommendations on the treatment of hepatitis are available at: http://www.cdc.gov/hepatitis/Resources/ Guidelines for the management of chronic hepatitis by the American Association for the Study of Liver Disease are available at: http://www.aasld.org HIV/AIDS: Guidelines for the treatment of HIV patients by the U.S. Department of Health and Human Services are available at: http://www.aidsinfo.nih.gov Infective Endocarditis: American Heart Association recommendations for the prevention of bacterial endocarditis are available at: http://www.myamericanheart.org Influenza: Recommendations of the Advisory Committee on Immunization Practices are available at: http://www.cdc.gov/ncidod/diseases/flu/fluvirus.htm International Travel: CDC recommendations for international travel are available at: http://www.cdc.gov/travel Sexually Transmitted Diseases: CDC Sexually Transmitted Diseases Guidelines are available at: http://www.cdc.gov/std/treatment/default.htm Respiratory Tract Infection/Antibiotic Use/Community Acquired Pneumonia/Other: Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infection in adults are available at: http://www.cdc.gov/flu/ Practice guidelines and statements developed and endorsed by the Infectious Diseases Society of America are available at: http://www.idsociety.org ANTIBACTERIALS Aminoglycosides neomycin sulfate tabs GP cephalexin caps 250 mg, 500 mg cefadroxil cephalexin susp cephalexin tabs 250 mg GP GNP GNP GNP cefaclor cefprozil cefuroxime axetil tabs CEFTIN GNP GNP GNP BNP Cephalosporins First Generation Second Generation PREFERRED ALTERNATIVES CEFTIN: cefuroxime GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 14 Third Generation cefdinir cefditoren cefixime susp 100 mg/5 mL, 200 mg/5 mL cefpodoxime ceftibuten CEDAX SPECTRACEF SUPRAX GNP GNP GNP GNP GNP BNP BNP BNP PREFERRED ALTERNATIVES CEDAX: ceftibuten SPECTRACEF: cefditoren SUPRAX susp 100 mg/5 mL, 200 mg/5 mL: cefixime susp 100 mg/5 mL, 200 mg/5 mL Erythromycins/Macrolides azithromycin tabs 250 mg azithromycin susp azithromycin tabs 500 mg, 600 mg clarithromycin clarithromycin ext-rel erythromycin erythromycin ethylsuccinate BIAXIN DIFICID ZITHROMAX ZMAX GP GNP GNP GNP GNP GNP GNP BNP BNP BNP BNP PREFERRED ALTERNATIVES BIAXIN: clarithromycin DIFICID: vancomycin ZITHROMAX: azithromycin ZMAX: azithromycin Fluoroquinolones ciprofloxacin levofloxacin ciprofloxacin ext-rel moxifloxacin ofloxacin AVELOX AVELOX ABC PACK FACTIVE LEVAQUIN GP GP GNP GNP GNP BNP BNP BNP BNP PREFERRED ALTERNATIVES AVELOX: moxifloxacin FACTIVE: ciprofloxacin, levofloxacin, moxifloxacin, ofloxacin LEVAQUIN: levofloxacin GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 15 Penicillins amoxicillin caps, susp, tabs amoxicillin chewable tabs ampicillin caps 250 mg penicillin VK amoxicillin ext-rel amoxicillin/clavulanate amoxicillin/clavulanate ext-rel ampicillin caps 500 mg ampicillin susp MOXATAG GP GP GP GP GNP GNP GNP GNP GNP BNP PREFERRED ALTERNATIVES MOXATAG: amoxicillin ext-rel Sulfonamides sulfamethoxazole/trimethoprim tabs sulfamethoxazole/trimethoprim susp GP GNP tetracycline caps 250 mg doxycycline hyclate caps 50 mg, 100 mg doxycycline hyclate tabs 20 mg, 100 mg doxycycline monohydrate minocycline minocycline ext-rel tetracycline caps 500 mg ADOXA AVIDOXY DORYX SOLODYN GP GNP GNP GNP GNP GNP GNP BNP BNP BNP BNP Tetracyclines PREFERRED ALTERNATIVES ADOXA: doxycycline monohydrate AVIDOXY: doxycycline monohydrate DORYX: doxycycline hyclate SOLODYN: minocycline ext-rel ANTIFUNGALS PAR PAR fluconazole tabs 50 mg, 150 mg clotrimazole troches fluconazole susp fluconazole tabs 100 mg, 200 mg griseofulvin ultramicrosize itraconazole nystatin terbinafine voriconazole CRESEMBA GP GNP GNP GNP GNP GNP GNP GNP GNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 16 DIFLUCAN LAMISIL SPORANOX VFEND PAR BNP BNP BNP BNP PREFERRED ALTERNATIVES CRESEMBA: voriconazole DIFLUCAN: fluconazole LAMISIL: terbinafine SPORANOX: itraconazole VFEND: voriconazole ANTIMALARIALS atovaquone/proguanil mefloquine COARTEM GNP GNP BNP ANTIRETROVIRAL AGENTS-M Brand-name products with FDA-approved generic equivalents are Non-Preferred. Antiretroviral Combinations-M abacavir/lamivudine/zidovudine lamivudine/zidovudine ATRIPLA COMPLERA EPZICOM ODEFSEY STRIBILD TRUVADA EVOTAZ PREZCOBIX TRIUMEQ TRIZIVIR GNP GNP BP BP BP BP BP BP BNP BNP BNP BNP Chemokine Receptor Antagonists-M SELZENTRY BP Fusion Inhibitors-M SRx FUZEON BP ISENTRESS TIVICAY BP BNP Integrase Inhibitors-M Non-nucleoside Reverse Transcriptase Inhibitors-M nevirapine nevirapine ext-rel EDURANT INTELENCE RESCRIPTOR SUSTIVA GNP GNP BP BP BP BP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 17 VIRAMUNE XR BNP Nucleoside Reverse Transcriptase Inhibitors-M abacavir tabs didanosine delayed-rel lamivudine stavudine zidovudine EMTRIVA VIDEX soln ZIAGEN soln 20 mg/mL GNP GNP GNP GNP GNP BP BP BP Nucleotide Reverse Transcriptase Inhibitors-M VIREAD BP Protease Inhibitors-M APTIVUS CRIXIVAN INVIRASE KALETRA LEXIVA NORVIR PREZISTA REYATAZ VIRACEPT BP BP BP BP BP BP BP BP BP isoniazid tabs 300 mg ethambutol isoniazid syrup isoniazid tabs 100 mg rifampin SIRTURO GP GNP GNP GNP GNP BNP valganciclovir VALCYTE GNP BNP ANTITUBERCULAR AGENTS PAR ANTIVIRALS Cytomegalovirus Agents PREFERRED ALTERNATIVES VALCYTE: valganciclovir Hepatitis Agents Hepatitis B SRx SRx entecavir lamivudine BARACLUDE EPIVIR-HBV GNP GNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 18 TYZEKA BNP PREFERRED ALTERNATIVES BARACLUDE: entecavir EPIVIR-HBV: lamivudine TYZEKA: lamivudine Hepatitis C SRx SRx SRx SRx PAR, SRx PAR, SRx SRx SRx Moderiba tabs Ribapak Ribasphere ribavirin HARVONI SOVALDI COPEGUS REBETOL GNP GNP GNP GNP BP BP BNP BNP PREFERRED ALTERNATIVES COPEGUS: ribavirin Herpes Agents acyclovir caps 200 mg acyclovir tabs 400 mg, 800 mg famciclovir valacyclovir DENAVIR FAMVIR VALTREX GP GNP GNP GNP BNP BNP BNP PREFERRED ALTERNATIVES FAMVIR: famciclovir VALTREX: valacyclovir Influenza Agents QLL QLL TAMIFLU RELENZA BP BNP PREFERRED ALTERNATIVES RELENZA: TAMIFLU MISCELLANEOUS clindamycin caps 150 mg, 300 mg metronidazole tabs 250 mg, 500 mg trimethoprim ivermectin linezolid nitrofurantoin ext-rel nitrofurantoin macrocrystals vancomycin SIVEXTRO MACROBID GP GP GP GNP GNP GNP GNP GNP BP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 19 VANCOCIN XIFAXAN 550 mg ZYVOX BNP BNP BNP PREFERRED ALTERNATIVES MACROBID: nitrofurantoin ext-rel VANCOCIN: vancomycin ZYVOX: linezolid ANTINEOPLASTIC AGENTS Clinical practice guidelines in oncology are available at: http://www.asco.org http://www.nccn.org ALKYLATING AGENTS SRx SRx SRx ANTIMETABOLITES SRx SRx temozolomide VALCHLOR TEMODAR GNP BP BNP capecitabine mercaptopurine XELODA GNP GNP BNP leucovorin 5 mg leucovorin 10 mg, 15 mg, 25 mg GP GNP CYTOPROTECTIVE AGENTS HORMONAL ANTINEOPLASTIC AGENTS Antiandrogens bicalutamide PAR, SRx XTANDI PAR, SRx ZYTIGA CASODEX GNP BP BP BNP Antiestrogens PAR*, PHC GNP tamoxifen *PAR is needed for coverage under PHC. Limited to women age 35 years and older with no previous history of breast cancer, ductal carcinoma in situ (CIS) or lobular carcinoma in situ. Aromatase Inhibitors anastrozole letrozole ARIMIDEX FEMARA GNP GNP BNP BNP PREFERRED ALTERNATIVES FEMARA: letrozole Gonadotropin Releasing Hormone (GnRH) Antagonists SRx FIRMAGON BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 20 Luteinizing Hormone-releasing Hormone (LHRH) Agonists SRx leuprolide acetate SRx ELIGARD SRx LUPRON DEPOT GNP BP BP Progestins megestrol acetate tabs 20 mg megestrol acetate tabs 40 mg GP GNP IMMUNOMODULATORS SRx SRx PAR, SRx REVLIMID THALOMID POMALYST BP BP BNP KINASE INHIBITORS SRx SRx PAR, SRx SRx PAR, SRx PAR, SRx PAR, SRx PAR, SRx PAR, SRx PAR, SRx PAR, SRx SRx PAR, SRx PAR, SRx PAR, SRx SRx SRx PAR, SRx SRx PAR, SRx PAR, SRx PAR, SRx SRx SRx SRx SRx SRx PAR, SRx PAR, SRx SRx PAR, SRx imatinib mesylate AFINITOR ALECENSA CAPRELSA COMETRIQ COTELLIC GILOTRIF IBRANCE ICLUSIG IMBRUVICA INLYTA IRESSA JAKAFI LENVIMA MEKINIST NEXAVAR SPRYCEL STIVARGA SUTENT TAFINLAR TAGRISSO TARCEVA TASIGNA TYKERB VOTRIENT XALKORI ZELBORAF ZYKADIA BOSULIF GLEEVEC ZYDELIG GNP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BP BNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 21 TOPOISOMERASE INHIBITORS SRx HYCAMTIN caps BP MISCELLANEOUS SRx PAR, SRx PAR, SRx PAR, SRx SRx PAR, SRx PAR, SRx SRx SRx PAR, SRx SRx GNP BP BP BP BP BP BP BP BP BNP BNP bexarotene ERIVEDGE LONSURF LYNPARZA MATULANE NINLARO ODOMZO TARGRETIN gel ZOLINZA FARYDAK TARGRETIN caps CARDIOVASCULAR The Eighth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure is available at: http://jama.jamanetwork.com/article.aspx?articleid=1791497 Guidelines for the evaluation and management of cardiovascular diseases in adults are available at: http://www.acc.org http://www.heartfailureguideline.org http://www.myamericanheart.org ACE INHIBITORS-M Guidelines for the use of ACE inhibitors are available at: http://jama.jamanetwork.com/article.aspx?articleid=1791497 http://professional.diabetes.org http://www.acc.org http://www.myamericanheart.org PAR PAR PAR benazepril enalapril fosinopril lisinopril quinapril ramipril captopril moexipril perindopril trandolapril ACCUPRIL ACEON ALTACE GP GP GP GP GP GP GNP GNP GNP GNP BNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 22 PAR MAVIK BNP PREFERRED ALTERNATIVES ACCUPRIL: quinapril ACEON: perindopril ALTACE: ramipril MAVIK: trandolapril ACE INHIBITOR/CALCIUM CHANNEL BLOCKER COMBINATIONS-M amlodipine/benazepril trandolapril/verapamil ext-rel PAR LOTREL PAR PRESTALIA PAR TARKA GNP GNP BNP BNP BNP PREFERRED ALTERNATIVES LOTREL: amlodipine/benazepril PRESTALIA: amlodipine/benazepril, trandolapril/verapamil ext-rel TARKA: trandolapril/verapamil ext-rel ACE INHIBITOR/DIURETIC COMBINATIONS-M * enalapril/hydrochlorothiazide lisinopril/hydrochlorothiazide benazepril/hydrochlorothiazide captopril/hydrochlorothiazide fosinopril/hydrochlorothiazide moexipril/hydrochlorothiazide quinapril/hydrochlorothiazide GP GP GNP GNP GNP GNP GNP * Brand Non-preferred ACE Inhibitor/Diuretic Combinations will require prior authorization. ADRENOLYTICS, CENTRAL-M clonidine guanfacine tabs 1 mg clonidine transdermal guanfacine tabs 2 mg CATAPRES-TTS ALDOSTERONE RECEPTOR ANTAGONISTS-M spironolactone tabs 25 mg eplerenone spironolactone tabs 50 mg, 100 mg INSPRA GP GP GNP GNP BNP GP GNP GNP BNP PREFERRED ALTERNATIVES INSPRA: eplerenone ALPHA BLOCKERS-M Guidelines for the use of alpha blockers in various patient populations are available at: http://jama.jamanetwork.com/article.aspx?articleid=1791497 prazosin 1 mg GP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 23 terazosin doxazosin prazosin 2 mg, 5 mg GP GNP GNP ANGIOTENSIN II RECEPTOR ANTAGONISTS/DIURETIC COMBINATIONS-M Guidelines for the use of angiotensin II receptor antagonists in various patient populations are available at: http://jama.jamanetwork.com/article.aspx?articleid=1791497 http://professional.diabetes.org PAR PAR PAR PAR PAR PAR PAR PAR PAR PAR PAR candesartan candesartan/hydrochlorothiazide eprosartan irbesartan irbesartan/hydrochlorothiazide losartan losartan/hydrochlorothiazide telmisartan telmisartan/hydrochlorothiazide valsartan valsartan/hydrochlorothiazide BENICAR BENICAR HCT ATACAND ATACAND HCT AVALIDE AVAPRO COZAAR DIOVAN DIOVAN HCT EDARBI HYZAAR MICARDIS MICARDIS HCT GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP BP BP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ATACAND: candesartan ATACAND HCT: candesartan/hctz AVALIDE: irbesartan/hctz AVAPRO: irbesartan COZAAR: losartan DIOVAN: valsartan DIOVAN HCT: valsartan/hctz HYZAAR: losartan/hctz MICARDIS: telmisartan MICARDIS HCT: telmisartan/hctz ANGIOTENSIN II RECEPTOR ANTAGONIST/CALCIUM CHANNEL BLOCKER COMBINATIONS-M amlodipine/valsartan GNP telmisartan/amlodipine GNP AZOR BP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 24 PAR EXFORGE BNP PREFERRED ALTERNATIVES EXFORGE: amlodipine/valsartan ANGIOTENSIN II RECEPTOR ANTAGONIST/CALCIUM CHANNEL BLOCKER/DIURETIC COMBINATIONS-M amlodipine/valsartan/hydrochlorothiazide GNP TRIBENZOR BP PAR EXFORGE HCT BNP PREFERRED ALTERNATIVES EXFORGE HCT: amlodipine/valsartan/hydrochlorothiazide ANTIARRHYTHMICS-M Guidelines for the use of antiarrhythmics and cardiac glycosides in various patient populations are available at: http://www.acc.org amiodarone tabs 200 mg sotalol tabs 80 mg, 160 mg amiodarone tabs 100 mg, 400 mg flecainide propafenone quinidine gluconate quinidine sulfate tabs sotalol tabs 120 mg, 240 mg TIKOSYN SRx GP GP GNP GNP GNP GNP GNP GNP BP ANTILIPEMICS-M The 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults is available at: http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437738.63853.7a Bile Acid Resins-M cholestyramine colestipol WELCHOL Cholesterol Absorption Inhibitors-M ZETIA GNP GNP BP BP Fibrates-M fenofibrate fenofibric acid delayed-rel gemfibrozil ANTARA LOFIBRA TRICOR TRILIPIX GNP GNP GNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ANTARA: fenofibrate LOFIBRA: fenofibrate GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 25 TRICOR: fenofibrate TRILIPIX: fenofibric acid delayed-rel HMG-CoA Reductase Inhibitors/Combinations-M QLL lovastatin EPA*, QLL simvastatin QLL atorvastatin QLL fluvastatin QLL fluvastatin ext-rel QLL pravastatin QLL rosuvastatin EPA**, QLL VYTORIN PAR, QLL ALTOPREV PAR, QLL CRESTOR PAR, QLL LESCOL XL PAR, QLL LIPITOR PAR, QLL LIVALO PAR, QLL MEVACOR PAR, QLL PRAVACHOL PAR, QLL ZOCOR GP GP GNP GNP GNP GNP GNP BP BNP BNP BNP BNP BNP BNP BNP BNP *EPA only applies to simvastatin 80 mg **EPA only applies to VYTORIN 10 mg-80 mg PREFERRED ALTERNATIVES ALTOPREV: atorvastatin, fluvastatin, fluvastatin ext-rel, lovastatin, rosuvastatin, simvastatin LESCOL XL: fluvastatin ext-rel LIPITOR: atorvastatin LIVALO: atorvastatin, fluvastatin, fluvastatin ext-rel, lovastatin, rosuvastatin, simvastatin MEVACOR: lovastatin PRAVACHOL: pravastatin ZOCOR: simvastatin Niacins-M niacin ext-rel NIASPAN GNP BNP PREFERRED ALTERNATIVES NIASPAN: niacin ext-rel Omega-3 Fatty Acids-M omega-3 acid ethyl esters LOVAZA VASCEPA GNP BNP BNP PREFERRED ALTERNATIVES LOVAZA: omega-3 acid ethyl esters VASCEPA: omega-3 acid ethyl esters PCSK9 Inhibitors-M PAR, SRx PAR, SRx PRALUENT REPATHA BP BP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 26 Miscellaneous-M PAR, SRx PAR, SRx JUXTAPID KYNAMRO BP BNP BETA-BLOCKERS-M Guidelines for the use of beta-blockers and beta-blocker combinations in various patient populations are available at: http://jama.jamanetwork.com/article.aspx?articleid=1791497 http://www.acc.org atenolol carvedilol metoprolol tartrate propranolol tabs 10 mg, 20 mg, 40 mg, 80 mg bisoprolol labetalol metoprolol succinate ext-rel nadolol propranolol ext-rel propranolol soln propranolol tabs 60 mg BYSTOLIC COREG COREG CR INDERAL LA TOPROL-XL GP GP GP GP GNP GNP GNP GNP GNP GNP GNP BP BNP BNP BNP BNP PREFERRED ALTERNATIVES COREG: carvedilol COREG CR: carvedilol INDERAL LA: propranolol ext-rel TOPROL-XL: metoprolol succinate ext-rel BETA-BLOCKER/DIURETIC COMBINATIONS-M Guidelines for the use of beta-blockers and diuretic combinations in various patient populations are available at: http://jama.jamanetwork.com/article.aspx?articleid=1791497 http://www.acc.org atenolol/chlorthalidone bisoprolol/hydrochlorothiazide DUTOPROL CALCIUM CHANNEL BLOCKERS-M Dihydropyridines-M amlodipine felodipine ext-rel isradipine nicardipine nifedipine nifedipine ext-rel nisoldipine ext-rel NORVASC GP GP BP GP GNP GNP GNP GNP GNP GNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 27 SULAR BNP PREFERRED ALTERNATIVES NORVASC: amlodipine SULAR: nisoldipine ext-rel Nondihydropyridines-M diltiazem 30 mg, 60 mg, 120 mg verapamil diltiazem 90 mg diltiazem ext-rel Matzim LA verapamil ext-rel CARDIZEM CARDIZEM CD CARDIZEM LA VERELAN PM PAR PAR PAR PAR GP GP GNP GNP GNP GNP BNP BNP BNP BNP PREFERRED ALTERNATIVES CARDIZEM: diltiazem ext-rel CARDIZEM CD: diltiazem ext-rel CARDIZEM LA: diltiazem ext-rel VERELAN PM: verapamil ext-rel CALCIUM CHANNEL BLOCKER/ANTILIPEMIC COMBINATIONS-M amlodipine/atorvastatin CADUET GNP BNP PREFERRED ALTERNATIVES CADUET: amlodipine/atorvastatin DIGITALIS GLYCOSIDES-M digoxin LANOXIN DIRECT RENIN INHIBITORS/DIURETIC COMBINATIONS-M TEKTURNA TEKTURNA HCT GNP BNP BP BP DIURETICS-M Loop Diuretics-M furosemide torsemide tabs 5 mg, 10 mg bumetanide torsemide tabs 20 mg, 100 mg DEMADEX LASIX GP GP GNP GNP BNP BNP PREFERRED ALTERNATIVES DEMADEX: torsemide LASIX: furosemide GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 28 Potassium-sparing Diuretics-M amiloride Thiazides and Thiazide-like Diuretics-M hydrochlorothiazide caps hydrochlorothiazide tabs 25 mg, 50 mg indapamide metolazone tabs 10 mg chlorthalidone hydrochlorothiazide tabs 12.5 mg metolazone tabs 2.5 mg, 5 mg GNP GP GP GP GP GNP GNP GNP Diuretic Combinations-M amiloride/hydrochlorothiazide triamterene/hydrochlorothiazide spironolactone/hydrochlorothiazide NEPRILYSIN INHIBITOR/ANGIOTENSIN II RECEPTOR ANTAGONIST COMBINATIONS-M PAR ENTRESTO GP GP GNP BP NITRATES-M Oral-M isosorbide mononitrate isosorbide mononitrate ext-rel tabs 30 mg isosorbide dinitrate isosorbide mononitrate ext-rel tabs 60 mg, 120 mg nitroglycerin tabs GP GP GNP GNP GNP nitroglycerin lingual spray NITROSTAT GNP BP Sublingual/Translingual-M NITRATE/VASODILATOR COMBINATIONS-M BIDIL BNP PREFERRED ALTERNATIVES BIDIL: isosorbide dinitrate + hydralazine PULMONARY ARTERIAL HYPERTENSION-M Endothelin Receptor Antagonists-M PAR, SRx LETAIRIS PAR, SRx OPSUMIT PAR, SRx TRACLEER BNP BNP BNP PREFERRED ALTERNATIVES LETAIRIS: sildenafil, ADCIRCA OPSUMIT: sildenafil, ADCIRCA TRACLEER: sildenafil, ADCIRCA Phosphodiesterase Inhibitors-M PAR, SRx sildenafil tabs 20 mg PAR, SRx ADCIRCA GNP BP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 29 PAR, SRx PAR, SRx REVATIO susp REVATIO tabs BP BNP PREFERRED ALTERNATIVES REVATIO tabs: sildenafil tabs Prostacyclin Receptor Agonists-M PAR, SRx UPTRAVI BNP Prostaglandin Vasodilators-M PAR, SRx SRx PAR, SRx PAR, SRx BNP BNP BNP BNP ORENITRAM REMODULIN TYVASO VENTAVIS Soluble Guanylate Cyclase Stimulators-M PAR, SRx ADEMPAS BP MISCELLANEOUS-M PAR PAR hydralazine tabs 10 mg methyldopa tabs 250 mg hydralazine tabs 25 mg, 50 mg, 100 mg methyldopa tabs 500 mg RANEXA CORLANOR GP GP GNP GNP BP BNP CENTRAL NERVOUS SYSTEM Practice guidelines for psychiatric disorders are available at: http://www.psych.org ANTIANXIETY Benzodiazepines alprazolam clonazepam tabs diazepam lorazepam tabs alprazolam ext-rel alprazolam orally disintegrating tabs clonazepam orally disintegrating tabs lorazepam oral concentrate GP GP GP GP GNP GNP GNP GNP buspirone tabs 5 mg, 10 mg, 15 mg buspirone tabs 7.5 mg, 30 mg fluvoxamine GP GNP GNP Miscellaneous ANTICONVULSANTS-M Practice guidelines for the treatment of epilepsy are available at: http://www.aan.com carbamazepine chews, tabs GP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 30 PAR divalproex sodium delayed-rel tabs 125 mg gabapentin caps 100 mg lamotrigine tabs 25 mg, 100 mg, 150 mg, 200 mg phenobarbital tabs 30 mg, 60 mg topiramate tabs 25 mg carbamazepine ext-rel carbamazepine susp diazepam rectal gel divalproex sodium delayed-rel tabs 250 mg, 500 mg divalproex sodium ext-rel gabapentin caps 300 mg, 400 mg gabapentin tabs, soln lamotrigine ext-rel lamotrigine orally disintegrating tabs lamotrigine tabs 50 mg levetiracetam levetiracetam ext-rel oxcarbazepine phenobarbital elixir phenobarbital tabs 15 mg, 16.2 mg, 32.4 mg, 64.8 mg, 97.2 mg, 100 mg phenytoin phenytoin sodium phenytoin sodium extended primidone tiagabine topiramate sprinkle caps topiramate tabs 50 mg, 100 mg, 200 mg valproic acid zonisamide APTIOM BANZEL CARBATROL DEPAKOTE DEPAKOTE ER DILANTIN DILANTIN INFATABS FYCOMPA KEPPRA KEPPRA XR LAMICTAL LAMICTAL ODT LAMICTAL XR NEURONTIN PHENYTEK POTIGA GP GP GP GP GP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 31 SRx SABRIL STAVZOR TEGRETOL-XR TOPAMAX TRILEPTAL VIMPAT ZONEGRAN BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES BANZEL: gabapentin, lamotrigine, levetiracetam CARBATROL: carbamazepine ext-rel DEPAKOTE: divalproex sodium delayed-rel DEPAKOTE ER: divalproex sodium ext-rel KEPPRA: levetiracetam KEPPRA XR: levetiracetam ext-rel LAMICTAL: lamotrigine LAMICTAL ODT: lamotrigine orally disintegrating tabs LAMICTAL XR: lamotrigine ext-rel NEURONTIN: gabapentin POTIGA: gabapentin, lamotrigine, levetiracetam STAVZOR: valproic acid TEGRETOL-XR: carbamazepine ext-rel TOPAMAX: topiramate TRILEPTAL: oxcarbazepine VIMPAT: gabapentin, lamotrigine, levetiracetam ZONEGRAN: zonisamide ANTIDEMENTIA-M Practice guidelines for the management of dementia are available at: http://www.aan.com EPA EPA EPA EPA donepezil donepezil orally disintegrating tabs galantamine galantamine ext-rel memantine rivastigmine NAMENDA XR ARICEPT EXELON NAMENDA RAZADYNE RAZADYNE ER GNP GNP GNP GNP GNP GNP BP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ARICEPT: donepezil EXELON: rivastigmine NAMENDA: memantine RAZADYNE: galantamine RAZADYNE ER: galantamine ext-rel GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 32 ANTIDEPRESSANTS-M Although these agents are primarily indicated for depression, some of these are also approved for other indications, including bipolar disorder, obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder. Guidelines for the evaluation and management of bipolar and depressive disorders are available at: http://www.psych.org Selective Serotonin Reuptake Inhibitors (SSRIs)-M QLL citalopram tabs QLL fluoxetine caps 10 mg, 20 mg QLL fluoxetine tabs 10 mg QLL paroxetine QLL sertraline tabs QLL citalopram soln QLL escitalopram QLL fluoxetine caps 40 mg QLL fluoxetine delayed-rel QLL fluoxetine soln QLL fluoxetine tabs 20 mg QLL paroxetine HCl ext-rel QLL sertraline oral concentrate PAR, QLL BRINTELLIX PAR, QLL CELEXA PAR, QLL LEXAPRO PAR, QLL PAXIL PAR, QLL PAXIL CR PAR, QLL PEXEVA PAR, QLL PROZAC PAR, QLL PROZAC WEEKLY PAR SARAFEM PAR VIIBRYD PAR, QLL ZOLOFT GP GP GP GP GP GNP GNP GNP GNP GNP GNP GNP GNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES CELEXA: citalopram LEXAPRO: escitalopram PAXIL: paroxetine PAXIL CR: paroxetine ext-rel PEXEVA: paroxetine PROZAC: fluoxetine PROZAC WEEKLY: fluoxetine delayed-rel VIIBRYD: citalopram, escitalopram, fluoxetine, paroxetine ZOLOFT: sertraline Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)-M duloxetine delayed-rel QLL Irenka venlafaxine QLL venlafaxine ext-rel PAR CYMBALTA PAR, QLL DESVENLAFAXINE ER GNP GNP GNP GNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 33 PAR, QLL PAR, QLL PAR, QLL PAR, QLL EFFEXOR XR FETZIMA KHEDEZLA PRISTIQ BNP BNP BNP BNP PREFERRED ALTERNATIVES CYMBALTA: duloxetine delayed-rel DESVENLAFAXINE ER: duloxetine delayed-rel, Irenka, venlafaxine, venlafaxine ext-rel EFFEXOR XR: venlafaxine ext-rel FETZIMA: duloxetine delayed-rel, Irenka, venlafaxine, venlafaxine ext-rel KHEDEZLA: duloxetine delayed-rel, Irenka, venlafaxine, venlafaxine ext-rel PRISTIQ: duloxetine delayed-rel, Irenka, venlafaxine, venlafaxine ext-rel Tricyclic Antidepressants (TCAs)-M amitriptyline 10 mg, 25 mg, 50 mg, 75 mg, 150 mg doxepin caps 10 mg doxepin oral concentrate imipramine HCl tabs 10 mg nortriptyline caps amitriptyline 100 mg desipramine doxepin caps 25 mg, 50 mg, 75 mg, 100 mg, 150 mg imipramine HCl tabs 25 mg, 50 mg imipramine pamoate nortriptyline soln protriptyline GP GP GP GP GP GNP GNP GNP GNP GNP GNP GNP Miscellaneous Agents-M PAR PAR PAR PAR PAR PAR mirtazapine tabs 15 mg trazodone tabs 50 mg, 100 mg, 150 mg bupropion bupropion ext-rel mirtazapine orally disintegrating tabs mirtazapine tabs 7.5 mg, 30 mg, 45 mg nefazodone trazodone tabs 300 mg APLENZIN EMSAM OLEPTRO WELLBUTRIN WELLBUTRIN SR WELLBUTRIN XL GP GP GNP GNP GNP GNP GNP GNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES APLENZIN: bupropion ext-rel EMSAM: citalopram, paroxetine OLEPTRO: trazodone WELLBUTRIN: bupropion WELLBUTRIN SR: bupropion ext-rel WELLBUTRIN XL: bupropion ext-rel GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 34 ANTIPARKINSONIAN AGENTS-M Practice guidelines for the diagnosis and treatment of Parkinson's disease are available at: http://www.aan.com benztropine amantadine bromocriptine carbidopa/levodopa carbidopa/levodopa orally disintegrating tabs carbidopa/levodopa/entacapone entacapone pramipexole pramipexole ext-rel ropinirole ropinirole ext-rel APOKYN NEUPRO COMTAN MIRAPEX MIRAPEX ER REQUIP REQUIP XL STALEVO SRx EPA GP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP BP BP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES COMTAN: entacapone MIRAPEX: pramipexole MIRAPEX ER: pramipexole ext-rel REQUIP: ropinirole REQUIP XL: ropinirole ext-rel STALEVO: carbidopa/levodopa/entacapone ANTIPSYCHOTICS-M Atypicals-M QLL QLL QLL QLL PAR PAR PAR PAR, QLL risperidone tabs 1 mg aripiprazole clozapine olanzapine olanzapine orally disintegrating tabs olanzapine/fluoxetine paliperidone ext-rel quetiapine risperidone orally disintegrating tabs risperidone tabs 0.25 mg, 0.5 mg, 2 mg, 3 mg, 4 mg ziprasidone ABILIFY FANAPT GEODON INVEGA GP GNP GNP GNP GNP GNP GNP GNP GNP GNP GNP BNP BNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 35 PAR PAR PAR PAR PAR PAR PAR, QLL PAR PAR PAR, QLL PAR, QLL LATUDA REXULTI RISPERDAL RISPERDAL M-TABS SAPHRIS SEROQUEL SEROQUEL XR SYMBYAX VRAYLAR ZYPREXA ZYPREXA ZYDIS BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ABILIFY: aripiprazole FANAPT: aripiprazole, olanzapine, paliperidone ext-rel, quetiapine, risperidone, ziprasidone GEODON: ziprasidone INVEGA: paliperidone ext-rel LATUDA: aripiprazole, olanzapine, paliperidone ext-rel, quetiapine, risperidone, ziprasidone REXULTI: aripiprazole, olanzapine, paliperidone ext-rel, quetiapine, risperidone, ziprasidone RISPERDAL: risperidone RISPERDAL M-TABS: risperidone orally disintegrating tabs SAPHRIS: aripiprazole, olanzapine, paliperidone ext-rel, quetiapine, risperidone, ziprasidone SEROQUEL: quetiapine SEROQUEL XR: quetiapine SYMBYAX: olanzapine/fluoxetine VRAYLAR: aripiprazole, olanzapine, paliperidone ext-rel, quetiapine, risperidone, ziprasidone ZYPREXA: olanzapine ZYPREXA ZYDIS: olanzapine orally disintegrating tabs Miscellaneous-M haloperidol oral concentrate thioridazine tabs 50 mg haloperidol tabs thioridazine tabs 10 mg, 25 mg, 100 mg GP GP GNP GNP ATTENTION DEFICIT HYPERACTIVITY DISORDER Guidelines for the evaluation and management of attention deficit disorder are available at: http://www.aacap.org http://www.aap.org PAR amphetamine/dextroamphetamine mixed salts amphetamine/dextroamphetamine mixed salts ext-rel clonidine ext-rel dexmethylphenidate dexmethylphenidate ext-rel dextroamphetamine guanfacine ext-rel methylphenidate methylphenidate ext-rel VYVANSE ADDERALL GNP GNP GNP GNP GNP GNP GNP GNP GNP BP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 36 PAR PAR ADDERALL XR CONCERTA DAYTRANA DYANAVEL XR FOCALIN FOCALIN XR INTUNIV KAPVAY METADATE CD METHYLIN PROCENTRA RITALIN LA STRATTERA PAR PAR PAR PAR PAR PAR PAR PAR PAR BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ADDERALL: amphetamine/dextroamphetamine mixed salts ADDERALL XR: amphetamine/dextroamphetamine mixed salts ext-rel CONCERTA: methylphenidate ext-rel DAYTRANA: methylphenidate ext-rel DYANAVEL XR: amphetamine/dextroamphetamine mixed salts ext-rel FOCALIN: dexmethylphenidate FOCALIN XR: dexmethylphenidate ext-rel INTUNIV: guanfacine ext-rel KAPVAY: clonidine ext-rel METADATE CD: methylphenidate ext-rel METHYLIN: methylphenidate PROCENTRA: dextroamphetamine RITALIN LA: methylphenidate ext-rel STRATTERA: amphetamine/dextroamphetamine mixed salts, amphetamine/dextroamphetamine mixed salts ext-rel, dexmethylphenidate, dexmethylphenidate ext-rel, dextroamphetamine, methylphenidate, methylphenidate ext-rel FIBROMYALGIA-M EPA EPA LYRICA SAVELLA HUNTINGTON'S DISEASE AGENTS-M PAR, SRx tetrabenazine PAR, SRx XENAZINE BP BP GNP BNP PREFERRED ALTERNATIVES XENAZINE: tetrabenazine HYPNOTICS Practice parameters for the treatment of sleep disorders and clinical guidelines for the evaluation and management of chronic insomnia in adults are available at: http://www.aasmnet.org Benzodiazepines flurazepam caps 30 mg temazepam caps 15 mg, 30 mg flurazepam caps 15 mg temazepam caps 7.5 mg, 22.5 mg GP GP GNP GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 37 Nonbenzodiazepines QLL QLL QLL QLL QLL EPA, QLL EPA, QLL PAR EPA, QLL PAR, SRx EPA, QLL EPA, QLL EPA, QLL EPA, QLL triazolam GNP zolpidem eszopiclone zaleplon zolpidem ext-rel zolpidem sublingual ROZEREM AMBIEN AMBIEN CR BELSOMRA EDLUAR HETLIOZ INTERMEZZO LUNESTA SONATA ZOLPIMIST GP GNP GNP GNP GNP BP BNP BNP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES AMBIEN: zolpidem AMBIEN CR: zolpidem ext-rel BELSOMRA: eszopiclone, zaleplon, zolpidem, zolpidem ext-rel, zolpidem sublingual, ROZEREM EDLUAR: zolpidem, zolpidem sublingual INTERMEZZO: zolpidem sublingual LUNESTA: eszopiclone SONATA: zaleplon ZOLPIMIST: zolpidem, zolpidem sublingual MIGRAINE Guidelines for prevention and management of migraine headaches are available at: http://www.aan.com Selective Serotonin Agonists QLL QLL QLL QLL QLL QLL QLL QLL EPA, QLL EPA, QLL EPA, QLL EPA, QLL EPA, QLL EPA, QLL EPA, QLL EPA, QLL almotriptan frovatriptan naratriptan rizatriptan rizatriptan orally disintegrating tabs sumatriptan zolmitriptan zolmitriptan orally disintegrating tabs AMERGE AXERT FROVA IMITREX MAXALT MAXALT-MLT RELPAX SUMAVEL DOSEPRO GNP GNP GNP GNP GNP GNP GNP GNP BNP BNP BNP BNP BNP BNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 38 EPA, QLL EPA, QLL ZOMIG ZOMIG-ZMT BNP BNP PREFERRED ALTERNATIVES AMERGE: naratriptan AXERT: almotriptan FROVA: frovatriptan IMITREX: sumatriptan MAXALT: rizatriptan MAXALT-MLT: rizatriptan orally disintegrating tabs RELPAX: almotriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, zolmitriptan ZOMIG: zolmitriptan ZOMIG-ZMT: zolmitriptan orally disintegrating tabs Selective Serotonin Agonist/Nonsteroidal Anti-inflammatory Drug (NSAID) Combinations EPA, QLL TREXIMET BNP PREFERRED ALTERNATIVES TREXIMET: sumatriptan + naproxen MOOD STABILIZERS-M lithium carbonate caps, tabs lithium carbonate ext-rel caps 300 mg LITHIUM SOLN GP GNP BP MULTIPLE SCLEROSIS AGENTS-M Practice guidelines for multiple sclerosis are available at: http://www.aan.com SRx PAR, QLL, SRx SRx SRx SRx SRx SRx PAR, SRx SRx EPA, SRx EPA, SRx glatiramer AMPYRA AVONEX BETASERON COPAXONE 40 mg GILENYA TECFIDERA AUBAGIO COPAXONE 20 mg EXTAVIA REBIF GNP BP BP BP BP BP BP BNP BNP BNP BNP PREFERRED ALTERNATIVES AUBAGIO: glatiramer, AVONEX, BETASERON, COPAXONE 40 mg, GILENYA, TECFIDERA COPAXONE 20 mg: glatiramer EXTAVIA: glatiramer, AVONEX, BETASERON, COPAXONE 40 mg, GILENYA, TECFIDERA REBIF: glatiramer, AVONEX, BETASERON, COPAXONE 40 mg, GILENYA, TECFIDERA MUSCULOSKELETAL THERAPY AGENTS carisoprodol tabs 350 mg cyclobenzaprine tabs 5 mg, 10 mg methocarbamol baclofen tabs carisoprodol tabs 250 mg GP GP GP GNP GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 39 PAR NARCOLEPSY PAR PAR PAR PAR chlorzoxazone cyclobenzaprine tabs 7.5 mg metaxalone orphenadrine ext-rel tizanidine AMRIX SKELAXIN GNP GNP GNP GNP GNP BNP BNP armodafinil modafinil NUVIGIL PROVIGIL GNP GNP BNP BNP PREFERRED ALTERNATIVES NUVIGIL: armodafinil PROVIGIL: modafinil PSYCHOTHERAPEUTIC-MISCELLANEOUS Opioid Antagonists NARCAN NASAL SPRAY EVZIO BP BNP PREFERRED ALTERNATIVES EVZIO: NARCAN NASAL SPRAY Partial Opioid Agonist/Opioid Antagonist Combinations QLL buprenorphine/naloxone sublingual tabs QLL SUBOXONE FILM GNP BP Smoking Deterrents Treating Tobacco Use and Dependence: 2008 Update-Clinical Practice Guideline is available at: http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/tobacco/index.html PHC, QLL* PHC, QLL* PHC, QLL* PHC, QLL* PHC, QLL* PHC, QLL* PHC, QLL* bupropion ext-rel nicotine polacrilex gum nicotine polacrilex lozenge nicotine transdermal CHANTIX NICOTROL INHALER NICOTROL NS GNP GNP GNP GNP BP BP BP *QLL Limited to a 180 day treatment regimen. RESTLESS LEGS SYNDROME HORIZANT BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 40 ENDOCRINE AND METABOLIC ANDROGENS Clinical practice guidelines for the treatment of hypogonadism are available at: http://www.aace.com testosterone cypionate testosterone enanthate testosterone gel testosterone gel pump 1% ANDRODERM ANDROGEL 1% (50 mg), 1.62% AXIRON ANDROGEL 1% (25 mg) ANDROGEL PUMP 1% FORTESTA TESTIM VOGELXO GNP GNP GNP GNP BP BP BP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ANDROGEL 1% (25 mg): testosterone gel ANDROGEL PUMP 1%: testosterone gel pump 1% FORTESTA: testosterone gel TESTIM: testosterone gel VOGELXO: testosterone gel ANTIDIABETICS-M Guidelines of treatment and management of diabetes are available at: http://professional.diabetes.org Alpha-glucosidase Inhibitors-M acarbose miglitol GLYSET PRECOSE GNP GNP BNP BNP PREFERRED ALTERNATIVES GLYSET: miglitol PRECOSE: acarbose Amylin Analogs-M EPA SYMLINPEN BP metformin metformin ext-rel tabs 500 mg metformin ext-rel tabs metformin ext-rel tabs 750 mg FORTAMET GLUCOPHAGE XR GLUMETZA GP GP GNP GNP BNP BNP BNP Biguanides-M * PAR PAR PAR GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 41 PAR RIOMET BNP * refers to generic for GLUMETZA PREFERRED ALTERNATIVES FORTAMET: metformin ext-rel GLUCOPHAGE XR: metformin ext-rel GLUMETZA: metformin ext-rel RIOMET: metformin Biguanide/Sulfonylurea Combinations-M glyburide/metformin tabs 1.25/250 mg glipizide/metformin glyburide/metformin tabs 2.5/500 mg, 5/500 mg GLUCOVANCE METAGLIP GP GNP GNP BNP BNP PREFERRED ALTERNATIVES GLUCOVANCE: glyburide/metformin METAGLIP: glipizide/metformin Dipeptidyl Peptidase-4 (DPP-4) Inhibitors/Combinations-M alogliptin alogliptin/metformin alogliptin/pioglitazone JANUMET JANUMET XR JANUVIA JENTADUETO TRADJENTA PAR KAZANO PAR KOMBIGLYZE XR PAR NESINA PAR ONGLYZA PAR OSENI GNP GNP GNP BP BP BP BP BP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES KAZANO: alogliptin/metformin KOMBIGLYZE XR: alogliptin, alogliptin/metformin, alogliptin/pioglitazone, JANUMET, JANUMET XR, JANUVIA, JENTADUETO, TRADJENTA NESINA: alogliptin ONGLYZA: alogliptin, alogliptin/metformin, alogliptin/pioglitazone JANUMET, JANUMET XR, JANUVIA, JENTADUETO, TRADJENTA OSENI: alogliptin/pioglitazone Incretin Mimetic Agents-M PAR PAR TRULICITY VICTOZA BYDUREON BYETTA BP BP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 42 PAR TANZEUM BNP PREFERRED ALTERNATIVES BYDUREON: TRULICITY, VICTOZA BYETTA: TRULICITY, VICTOZA TANZEUM: TRULICITY, VICTOZA Insulins-M LANTUS LEVEMIR NOVOLIN 70/30 NOVOLIN N NOVOLIN R NOVOLOG NOVOLOG MIX 70/30 TOUJEO AFREZZA APIDRA HUMALOG HUMALOG MIX HUMULIN 70/30 HUMULIN N HUMULIN R RELION products TRESIBA PAR PAR PAR PAR PAR PAR PAR PAR BP BP BP BP BP BP BP BP BNP BNP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES AFREZZA: NOVOLOG APIDRA: NOVOLOG HUMALOG: NOVOLOG HUMULIN: NOVOLIN RELION products: NOVOLIN TRESIBA: LANTUS, LEVEMIR, TOUJEO Insulin Sensitizers-M pioglitazone ACTOS GNP BNP PREFERRED ALTERNATIVES ACTOS: pioglitazone Insulin Sensitizer/Biguanide Combinations-M pioglitazone/metformin ACTOPLUS MET XR ACTOPLUS MET GNP BP BNP PREFERRED ALTERNATIVES ACTOPLUS MET: pioglitazone/metformin GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 43 Insulin Sensitizer/Sulfonylurea Combinations-M pioglitazone/glimepiride DUETACT GNP BNP PREFERRED ALTERNATIVES DUETACT: pioglitazone/glimepiride Meglitinides-M nateglinide repaglinide PRANDIN STARLIX GNP GNP BNP BNP PREFERRED ALTERNATIVES PRANDIN: repaglinide STARLIX: nateglinide Meglitinide/Biguanide Combinations-M repaglinide/metformin GNP Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors-M FARXIGA JARDIANCE PAR INVOKANA BP BP BNP PREFERRED ALTERNATIVES INVOKANA: FARXIGA, JARDIANCE Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor/Biguanide Combinations-M XIGDUO XR PAR INVOKAMET BP BNP PREFERRED ALTERNATIVES INVOKAMET: XIGDUO XR Sulfonylureas-M glimepiride glipizide glipizide ext-rel tabs 2.5 mg, 5 mg glyburide micronized glyburide tabs 1.25 mg, 2.5 mg glipizide ext-rel tabs 10 mg glyburide tabs 5 mg AMARYL GP GP GP GP GP GNP GNP BNP PREFERRED ALTERNATIVES AMARYL: glimepiride Supplies-M NOVOFINE 30, 32 AUTOCOVER ONETOUCH SOFT TOUCH BP BP BP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 44 SOFTCLIX ACCU-CHEK ASCENSIA BREEZE CONTOUR FAST TAKE FREESTYLE PRECISION PCX PRECISION PCX PLUS PRECISION Q-I-D PRECISION SOF-TACT PRECISION XTRA SURESTEP PAR PAR PAR PAR PAR PAR PAR PAR PAR PAR PAR PAR BP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ACCU-CHEK: ONETOUCH ASCENSIA: ONETOUCH BREEZE: ONETOUCH CONTOUR: ONETOUCH FAST TAKE: ONETOUCH FREESTYLE: ONETOUCH PRECISION: ONETOUCH SURESTEP: ONETOUCH ANTIOBESITY Guidelines of treatment and management of obesity are available at: http://www.aace.com http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/obesity-evidence-review Injectable PAR SAXENDA BNP Oral PAR PAR PAR PAR BELVIQ CONTRAVE QSYMIA XENICAL BNP BNP BNP BNP PREFERRED ALTERNATIVES XENICAL: ALLI OTC* * OTC ALLI is not covered under the prescription drug benefit. CALCIUM RECEPTOR ANTAGONISTS-M SRx SENSIPAR BP CALCIUM REGULATORS-M Guidelines of treatment and management of osteoporosis are available at: http://www.aace.com http://www.nof.org Bisphosphonates-M QLL alendronate tabs 5 mg, 35 mg, 70 mg GP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 45 QLL QLL QLL EPA, QLL EPA, QLL EPA, QLL EPA, QLL EPA, QLL alendronate soln alendronate tabs 40 mg ibandronate tabs risedronate risedronate delayed-rel FOSAMAX PLUS D ACTONEL ATELVIA BONIVA tabs FOSAMAX GNP GNP GNP GNP GNP BP BNP BNP BNP BNP PREFERRED ALTERNATIVES ACTONEL: risedronate ATELVIA: risedronate delayed-rel BONIVA: ibandronate FOSAMAX: alendronate Calcitonins-M calcitonin-salmon MIACALCIN GNP BNP PREFERRED ALTERNATIVES MIACALCIN: calcitonin-salmon Parathyroid Hormones-M PAR, SRx PAR, SRx FORTEO NATPARA BP BNP Aviane Gianvi Junel Fe Lessina Lomedia 24 Fe Lutera Microgestin 1/20 Microgestin Fe 1/20 LOESTRIN 1/20 LOESTRIN FE 1/20 YAZ GNP GNP GNP GNP GNP GNP GNP GNP BNP BNP BNP CONTRACEPTIVES EE = ethinyl estradiol ME = mestranol Monophasic-M 20 mcg Estrogen-M PHC PHC PHC PHC PHC PHC PHC PHC PREFERRED ALTERNATIVES LOESTRIN: Microgestin LOESTRIN FE: Junel Fe, Microgestin Fe YAZ: Gianvi GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 46 30 mcg Estrogen-M PHC PHC PHC PHC PHC PHC PHC PHC Apri Cryselle Junel Fe Levora Low-Ogestrel Microgestin 1.5/30 Microgestin Fe 1.5/30 Ocella DESOGEN LOESTRIN 1.5/30 LOESTRIN FE 1.5/30 YASMIN GNP GNP GNP GNP GNP GNP GNP GNP BNP BNP BNP BNP PREFERRED ALTERNATIVES DESOGEN: Apri LOESTRIN: Microgestin LOESTRIN FE: Junel Fe, Microgestin Fe YASMIN: Ocella 35 mcg Estrogen-M PHC PHC PHC PHC PHC PHC PHC PHC PHC Kelnor 1/35 Mononessa Necon 0.5/35 Necon 1/35 Nortrel 0.5/35 Nortrel 1/35 Previfem Sprintec Zovia 1/35e ORTHO-CYCLEN ORTHO-NOVUM 1/35 GNP GNP GNP GNP GNP GNP GNP GNP GNP BNP BNP PREFERRED ALTERNATIVES ORTHO-CYCLEN: Previfem, Sprintec ORTHO-NOVUM: Nortrel 50 mcg Estrogen-M PHC Biphasic-M PHC Necon 1/50 GNP Kariva MIRCETTE GNP BNP PREFERRED ALTERNATIVES MIRCETTE: Kariva Triphasic-M PHC PHC PHC Aranelle Enpresse Necon 7/7/7 GNP GNP GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 47 PHC PHC PHC PHC PHC PHC PHC Nortrel 7/7/7 Tri-Lo Sprintec Trinessa Tri-Previfem Tri-Sprintec Trivora Velivet ESTROSTEP FE CYCLESSA ORTHO TRI-CYCLEN ORTHO TRI-CYCLEN LO ORTHO-NOVUM 7/7/7 TRI-NORINYL GNP GNP GNP GNP GNP GNP GNP BP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES CYCLESSA: Velivet ORTHO TRI-CYCLEN: Trinessa, Tri-Previfem, Tri-Sprintec ORTHO TRI-CYCLEN LO: Tri-Lo Sprintec ORTHO-NOVUM 7/7/7: Necon 7/7/7, Nortrel 7/7/7 TRI-NORINYL: Aranelle Four Phase-M PHC Extended Cycle-M PHC PHC PHC PHC PHC PHC PHC PHC NATAZIA BNP Amethia Amethia Lo Camrese Camrese Lo Introvale Jolessa levonorgestrel/EE 0.1/20 and EE 10 Quasense LOSEASONIQUE SEASONIQUE GNP GNP GNP GNP GNP GNP GNP GNP BNP BNP PREFERRED ALTERNATIVES LOSEASONIQUE: Amethia Lo, Camrese Lo, levonorgestrel/EE 0.1/20 and EE 10 SEASONIQUE: Amethia, Camrese Progestin Only-M PHC PHC PHC Camila Errin Jolivette GNP GNP GNP Emergency Contraception PHC PHC PHC levonorgestrel Next Choice One Dose ELLA GNP GNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 48 Injectable-M PHC, * * medroxyprogesterone acetate 150 mg/mL DEPO-PROVERA GNP BNP * Copays at retail pharmacy may vary due to package size. PREFERRED ALTERNATIVES DEPO-PROVERA: medroxyprogesterone acetate Transdermal-M PHC Xulane GNP Vaginal-M PHC NUVARING BP Miscellaneous OTC, PHC OTC, PHC GYNOL II GEL 3% VCF VAGINAL CONTRACEPTIVE FOAM BP BNP ENDOMETRIOSIS SRx SRx SYNAREL LUPANETA BP BNP ESTROGENS-M Guidelines of treatment and management of hormone therapy and menopause are available at: http://www.menopause.org https://www.aace.com/files/menopause.pdf Oral-M estradiol estropipate 0.75 mg, 3 mg estropipate 1.5 mg PREMARIN MENEST GP GP GNP BP BNP PREFERRED ALTERNATIVES MENEST: estradiol, PREMARIN Transdermal-M estradiol ALORA CLIMARA ESTROGEL MENOSTAR VIVELLE-DOT GNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ALORA: estradiol patch CLIMARA: estradiol patch ESTROGEL: estradiol patch MENOSTAR: estradiol, PREMARIN VIVELLE-DOT: estradiol patch GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 49 Vaginal-M ESTRING PREMARIN crm VAGIFEM BP BP BP estradiol/norethindrone Jinteli norethindrone/ethinyl estradiol 0.5 mg/2.5 mcg PREMPHASE PREMPRO ACTIVELLA FEMHRT 0.5 mg/2.5 mcg PREFEST GNP GNP GNP BP BP BNP BNP BNP ESTROGEN/PROGESTINS-M Oral-M PREFERRED ALTERNATIVES ACTIVELLA: estradiol/norethindrone FEMHRT 0.5 mg/2.5 mcg: norethindrone/ethinyl estradiol 0.5 mg/2.5 mcg PREFEST: PREMPRO, PREMPHASE Transdermal-M CLIMARA PRO COMBIPATCH BP BP ESTROGEN/SELECTIVE ESTROGEN RECEPTOR MODULATOR COMBINATIONS-M DUAVEE BNP FERTILITY REGULATORS GNRH/LHRH Antagonists SRx SRx BP BP CETROTIDE GANIRELIX Ovulation Stimulants, Gonadotropins SRx chorionic gonadotropin - Novarel SRx chorionic gonadotropin - Pregnyl SRx BRAVELLE SRx FOLLISTIM AQ SRx GONAL-F SRx GONAL-F RFF SRx MENOPUR SRx OVIDREL SRx REPRONEX GNP GNP BP BP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES GONAL-F: BRAVELLE, FOLLISTIM AQ GONAL-F RFF: BRAVELLE, FOLLISTIM AQ REPRONEX: BRAVELLE, FOLLISTIM AQ Ovulation Stimulants, Synthetic clomiphene GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 50 GLUCOCORTICOIDS dexamethasone tabs 0.5 mg, 0.75 mg, 1 mg, 1.5 mg, 4 mg, 6 mg prednisolone prednisolone sodium phosphate soln 15 mg/5 mL prednisone dose pack 5 mg prednisone tabs dexamethasone tabs 2 mg fludrocortisone hydrocortisone methylprednisolone prednisolone sodium phosphate soln 5 mg/5 mL, 25 mg/5 mL prednisone dose pack 10 mg prednisone soln GLUCOSE ELEVATING AGENTS GLUCAGEN GLUCAGON GP GP GP GP GP GNP GNP GNP GNP GNP GNP GNP BP BP HUMAN GROWTH HORMONES Guidelines for use of growth hormone are available at: http://www.aace.com/publications/guidelines PAR, SRx PAR, SRx PAR, SRx PAR, SRx PAR, SRx PAR, SRx PAR, SRx PAR, SRx PAR, SRx NORDITROPIN SEROSTIM GENOTROPIN HUMATROPE NUTROPIN AQ OMNITROPE SAIZEN ZOMACTON ZORBTIVE BP BP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES GENOTROPIN: NORDITROPIN HUMATROPE: NORDITROPIN NUTROPIN AQ: NORDITROPIN OMNITROPE: NORDITROPIN SAIZEN: NORDITROPIN ZOMACTON: NORDITROPIN HYPERPARATHYROID TREATMENT, VITAMIN D ANALOGS-M calcitriol doxercalciferol paricalcitol HECTOROL GNP GNP GNP BNP PREFERRED ALTERNATIVES HECTOROL: doxercalciferol GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 51 INSULIN-LIKE GROWTH FACTOR PAR, SRx INCRELEX BP PHENYLKETONURIA TREATMENT AGENTS SRx KUVAN BP PHOSPHATE BINDER AGENTS-M calcium acetate RENAGEL RENVELA FOSRENOL PHOSLO GNP BP BP BNP BNP PREFERRED ALTERNATIVES FOSRENOL: RENAGEL PHOSLO: calcium acetate PROGESTINS-M Oral-M medroxyprogesterone acetate megestrol acetate susp norethindrone acetate progesterone, micronized PROMETRIUM GP GNP GNP GNP BNP PREFERRED ALTERNATIVES PROMETRIUM: progesterone, micronized SELECTIVE ESTROGEN RECEPTOR MODULATORS-M PAR*, PHC raloxifene EVISTA OSPHENA GNP BNP BNP *PAR is needed for coverage under PHC. Limited to women age 35 years and older with no previous history of breast cancer, ductal carcinoma in situ (CIS) or lobular carcinoma in situ. PREFERRED ALTERNATIVES EVISTA: raloxifene THYROID AGENTS-M Antithyroid Agents-M methimazole tabs 5 mg methimazole tabs 10 mg propylthiouracil GP GNP GNP levothyroxine sodium 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg thyroid tabs levothyroxine sodium 175 mcg, 200 mcg, 300 mcg Levoxyl liothyronine GP Thyroid Supplements-M GP GNP GNP GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 52 CYTOMEL SYNTHROID BNP BNP PREFERRED ALTERNATIVES CYTOMEL: liothyronine SYNTHROID: levothyroxine VASOPRESSINS desmopressin STIMATE DDAVP GNP BP BNP PREFERRED ALTERNATIVES DDAVP: desmopressin MISCELLANEOUS SRx PAR, SRx PAR, SRx PAR, SRx PAR, SRx SRx SRx PAR, SRx PAR, SRx SRx PAR, SRx PAR, SRx PAR, SRx SRx SRx SRx octreotide CYSTAGON EGRIFTA KORLYM MYALEPT ORFADIN SANDOSTATIN LAR SIGNIFOR SOMATULINE SOMAVERT STRENSIQ ACTHAR HP PROCYSBI RAVICTI SAMSCA SANDOSTATIN GNP BP BP BP BP BP BP BP BP BP BP BNP BNP BNP BNP BNP GASTROINTESTINAL Guidelines for the treatment and management of various gastrointestinal diseases/conditions are available at: http://gi.org http://www.gastro.org ANTIDIARRHEALS EPA diphenoxylate/atropine FULYZAQ GNP BNP metoclopramide ondansetron orally disintegrating tabs 4 mg granisetron ondansetron orally disintegrating tabs 8 mg ondansetron tabs, soln prochlorperazine trimethobenzamide GP GP GNP GNP GNP GNP GNP ANTIEMETICS QLL QLL QLL QLL GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 53 QLL EPA, QLL QLL QLL QLL EPA, QLL QLL QLL EMEND AKYNZEO ANZEMET CESAMET SANCUSO VARUBI ZOFRAN ZUPLENZ BP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES AKYNZEO: granisetron, ondansetron ANZEMET: granisetron, ondansetron CESAMET: granisetron, ondansetron SANCUSO: granisetron, ondansetron VARUBI: granisetron, ondansetron ZOFRAN: ondansetron ANTISPASMODICS dicyclomine caps, tabs dicyclomine soln hyoscyamine sulfate GP GNP GNP ursodiol URSO URSO FORTE GNP BNP BNP CHOLELITHOLYTICS-M PREFERRED ALTERNATIVES URSO: ursodiol URSO FORTE: ursodiol H2 RECEPTOR ANTAGONISTS-M * cimetidine 300 mg, 400 mg, 800 mg famotidine 40 mg ranitidine tabs 300 mg nizatidine ranitidine caps, syrup GP GP GP GNP GNP * If a prescription drug has an available OTC equivalent, the prescription drug will not be covered. INFLAMMATORY BOWEL DISEASE Oral Agents-M balsalazide budesonide delayed-rel caps sulfasalazine ASACOL HD DELZICOL LIALDA PENTASA APRISO COLAZAL GNP GNP GNP BP BP BP BP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 54 DIPENTUM BNP PREFERRED ALTERNATIVES APRISO: DELZICOL, PENTASA COLAZAL: balsalazide DIPENTUM: sulfasalazine, DELZICOL, PENTASA Rectal Agents CANASA IRRITABLE BOWEL SYNDROME-M Irritable Bowel Syndrome with Constipation-M LINZESS PAR AMITIZA BP BP BNP PREFERRED ALTERNATIVES AMITIZA: LINZESS Irritable Bowel Syndrome with Diarrhea-M PAR VIBERZI BNP LAXATIVES peg 3350/electrolytes lactulose GOLYTELY KRISTALOSE GP GNP BNP BNP PREFERRED ALTERNATIVES GOLYTELY: peg 3350/electrolytes KRISTALOSE: lactulose OPIOID-INDUCED CONSTIPATION MOVANTIK PAR RELISTOR BP BNP PREFERRED ALTERNATIVES RELISTOR: MOVANTIK PANCREATIC ENZYMES-M CREON BP misoprostol GNP PROTON PUMP INHIBITORS-M * QLL omeprazole delayed-rel caps 20 mg QLL esomeprazole delayed-rel QLL lansoprazole delayed-rel QLL omeprazole delayed-rel caps 10 mg, 40 mg QLL omeprazole/sodium bicarbonate QLL pantoprazole delayed-rel QLL rabeprazole delayed-rel QLL DEXILANT GP GNP GNP GNP GNP GNP GNP BP PROSTAGLANDINS-M GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 55 PAR, QLL PAR, QLL PAR, QLL PAR, QLL PAR, QLL PAR, QLL PRILOSEC susp ACIPHEX NEXIUM PREVACID PRILOSEC PROTONIX ZEGERID BP BNP BNP BNP BNP BNP BNP * If a prescription drug has an available OTC equivalent, the prescription drug will not be covered. PREFERRED ALTERNATIVES ACIPHEX: rabeprazole NEXIUM: esomeprazole PREVACID: lansoprazole PRILOSEC: omeprazole PROTONIX: pantoprazole ZEGERID: omeprazole/sodium bicarbonate STEROIDS, RECTAL hydrocortisone rectal crm ULCER THERAPY COMBINATIONS lansoprazole + amoxicillin + clarithromycin PREVPAC GNP GNP BNP PREFERRED ALTERNATIVES PREVPAC: lansoprazole + amoxicillin + clarithromycin MISCELLANEOUS-M PAR, SRx SRx PAR, SRx cromolyn sodium oral concentrate sucralfate CHOLBAM CARBAGLU GATTEX GNP GNP BP BNP BNP GENITOURINARY BENIGN PROSTATIC HYPERPLASIA-M Guidelines for the management of BPH are available at: http://www.auanet.org/guidelines alfuzosin ext-rel dutasteride dutasteride/tamsulosin finasteride tamsulosin AVODART FLOMAX JALYN PROSCAR RAPAFLO GNP GNP GNP GNP GNP BNP BNP BNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 56 UROXATRAL BNP PREFERRED ALTERNATIVES AVODART: dutasteride FLOMAX: tamsulosin JALYN: dutasteride/tamsulosin PROSCAR: finasteride RAPAFLO: doxazosin, terazosin UROXATRAL: alfuzosin ext-rel ERECTILE DYSFUNCTION Guidelines for the management of erectile dysfunction are available at: http://www.auanet.org/guidelines Alprostadil Agents QLL QLL QLL CAVERJECT EDEX MUSE BNP BNP BNP PREFERRED ALTERNATIVES CAVERJECT: LEVITRA EDEX: LEVITRA MUSE: LEVITRA Phosphodiesterase Inhibitors QLL PAR QLL QLL QLL LEVITRA CIALIS 2.5 mg, 5 mg CIALIS 10 mg, 20 mg STAXYN VIAGRA BP BNP BNP BNP BNP PREFERRED ALTERNATIVES CIALIS: LEVITRA STAXYN: LEVITRA VIAGRA: LEVITRA URINARY ANTISPASMODICS-M oxybutynin syrup darifenacin ext-rel oxybutynin ext-rel oxybutynin tabs tolterodine tolterodine ext-rel trospium trospium ext-rel GELNIQUE VESICARE PAR DETROL PAR DETROL LA PAR DITROPAN XL PAR ENABLEX PAR MYRBETRIQ GP GNP GNP GNP GNP GNP GNP GNP BP BP BNP BNP BNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 57 PAR TOVIAZ BNP PREFERRED ALTERNATIVES DETROL: tolterodine DETROL LA: tolterodine ext-rel DITROPAN XL: oxybutynin ext-rel ENABLEX: darifenacin ext-rel MYRBETRIQ: darifenacin ext-rel, oxybutynin ext-rel, tolterodine, tolterodine ext-rel, trospium, trospium ext-rel TOVIAZ: darifenacin ext-rel, oxybutynin ext-rel, tolterodine, tolterodine ext-rel, trospium, trospium ext-rel MISCELLANEOUS phenazopyridine ELMIRON GP BP HEMATOLOGIC Guidelines of treatment and management of hemophilia are available at: http://www.hemophilia.org ANTICOAGULANTS CHEST guidelines are available at: http://www.chestnet.org/Guidelines-and-Resources/Guidelines-and-Consensus-Statements/Antithrombotic-Guidelines9th-Ed Injectable enoxaparin FRAGMIN LOVENOX GNP BP BNP warfarin ELIQUIS XARELTO COUMADIN PRADAXA SAVAYSA GP BP BP BNP BNP BNP Oral-M PREFERRED ALTERNATIVES COUMADIN: warfarin PRADAXA: warfarin, ELIQUIS, XARELTO SAVAYSA: warfarin, ELIQUIS, XARELTO Synthetic Heparinoid-like Agents fondaparinux ARIXTRA GNP BNP PREFERRED ALTERNATIVES ARIXTRA: fondaparinux ANTIHEMOPHILIC AGENTS SRx SRx SRx SRx ADVATE ALPHANATE ALPHANINE SD BEBULIN VH BP BP BP BP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 58 SRx SRx SRx SRx SRx SRx SRx SRx SRx SRx SRx SRx SRx SRx SRx SRx SRx SRx SRx BENEFIX FEIBA NF FEIBA VH HELIXATE FS HEMOFIL M HUMATE-P KOATE-DVI KOGENATE FS MONOCLATE-P MONONINE NOVOSEVEN RT PROFILNINE SD RECOMBINATE WILATE CORIFACT IXINITY NOVOEIGHT NUWIQ XYNTHA BP BP BP BP BP BP BP BP BP BP BP BP BP BP BNP BNP BNP BNP BNP HEMATOPOIETIC GROWTH FACTORS Guidelines for the management of neutropenia are available at: http://www.asco.org Guidelines for the management of anemia associated with chronic kidney disease are available at: http://www.kidney.org/professionals/kdoqi/guidelines_commentaries.cfm#guidelines PAR, SRx SRx SRx SRx SRx PAR, SRx PAR, SRx PAR, SRx SRx ARANESP GRANIX LEUKINE NEULASTA NEUPOGEN PROCRIT EPOGEN MIRCERA ZARXIO BP BP BP BP BP BP BNP BNP BNP PREFERRED ALTERNATIVES EPOGEN: PROCRIT MIRCERA: PROCRIT HEMOSTATICS tranexamic acid LYSTEDA GNP BNP PREFERRED ALTERNATIVES LYSTEDA: tranexamic acid HEREDITARY ANGIOEDEMA AGENTS SRx BERINERT BP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 59 SRx FIRAZYR BP IDIOPATHIC THROMBOCYTOPENIC PURPURA AGENTS-M SRx PROMACTA BP IRON CHELATING AGENTS PAR, SRx PAR, SRx BP BNP EXJADE FERRIPROX PLATELET AGGREGATION INHIBITORS-M AL, OTC, PHC, QLL, * aspirin 81 mg, 162 mg, 325 mg AL, OTC, PHC, QLL, * aspirin chew tabs AL, OTC, PHC, QLL, * aspirin delayed-rel 81 mg, 162 mg, 325 mg clopidogrel dipyridamole dipyridamole ext-rel/aspirin EFFIENT AGGRENOX PLAVIX ZONTIVITY GNP GNP GNP GNP GNP GNP BP BNP BNP BNP * Limited to one dose per day (≤325 mg) for men ages 45 to 79 and women ages 55 to 79. PREFERRED ALTERNATIVES AGGRENOX: dipyridamole ext-rel/aspirin PLAVIX: clopidogrel PLATELET SYNTHESIS INHIBITORS-M anagrelide GNP STEM CELL MOBILIZERS PAR, SRx MOZOBIL BP cilostazol pentoxifylline ext-rel CYSTADANE JADENU GNP GNP BNP BNP MISCELLANEOUS-M SRx PAR, SRx IMMUNOLOGIC AGENTS Guidelines for the management of rheumatic diseases are available at: http://www.rheumatology.org BIOLOGIC DISEASE-MODIFYING AGENTS PAR, QLL, SRx ENBREL PAR, QLL, SRx HUMIRA PAR, QLL, SRx ACTEMRA 162 mg/0.9 mL PAR, QLL, SRx CIMZIA PAR, QLL, SRx KINERET PAR, QLL, SRx ORENCIA 125 mg/mL BP BP BNP BNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 60 PAR, QLL, SRx SIMPONI BNP PREFERRED ALTERNATIVES ACTEMRA 162 mg/0.9 mL: ENBREL, HUMIRA CIMZIA: ENBREL, HUMIRA ORENCIA 125 mg/mL: ENBREL, HUMIRA KINERET: ENBREL, HUMIRA SIMPONI: ENBREL, HUMIRA DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs)-M hydroxychloroquine methotrexate oral SRx OTREXUP PAR, SRx XELJANZ PAR, SRx XELJANZ XR GNP GNP BNP BNP BNP PREFERRED ALTERNATIVES XELJANZ: ENBREL, HUMIRA XELJANZ XR: ENBREL, HUMIRA IMMUNE GLOBULINS SRx SRx HIZENTRA HYQVIA BNP BNP IMMUNOMODULATORS-M CDC recommendations on the treatment of hepatitis are available at: http://www.cdc.gov/hepatitis/Resources/ Guidelines for the management of hepatitis are available at: http://www.aasld.org Interferons-M SRx SRx SRx EPA, SRx EPA, SRx PAR, SRx ACTIMMUNE INTRON A PEGASYS PEGINTRON PEGINTRON REDIPEN SYLATRON BP BP BP BNP BNP BNP PREFERRED ALTERNATIVES PEGINTRON: PEGASYS PEGINTRON REDIPEN: PEGASYS Miscellaneous-M SRx PAR, SRx ARCALYST OTEZLA BP BNP PREFERRED ALTERNATIVES OTEZLA: ENBREL, HUMIRA IMMUNOSUPPRESSANTS-M Antimetabolites-M azathioprine mycophenolate mofetil GNP GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 61 mycophenolate sodium delayed-rel CELLCEPT GNP BNP PREFERRED ALTERNATIVES CELLCEPT: mycophenolate Calcineurin Inhibitors-M cyclosporine cyclosporine, modified tacrolimus GNP GNP GNP sirolimus ZORTRESS GNP BP Rapamycin Derivatives-M NUTRITIONAL/SUPPLEMENTS ELECTROLYTES Potassium-M potassium chloride effervescent tabs 25 mEq potassium chloride oral liq 10%, 20% Potassium-Removing Agents PAR, SRx VELTASSA VITAMINS AND MINERALS Folic Acid Agents-M AL, OTC, PHC, QLL, * folic acid tabs 0.4 mg, 0.8 mg folic acid tabs 1 mg GP GNP BNP GP GP * Limited to one dose per day (0.4 mg to 0.8 mg) for women through age 55. Prenatal Vitamins Prenatabs FA Prenatal Plus DUET DHA PRENATE ELITE GP GP BNP BNP PREFERRED ALTERNATIVES DUET DHA: generics PRENATE ELITE: generics Miscellaneous AL, OTC, PHC, * AL, OTC, PHC, QLL, ** AL, OTC, PHC, QLL, ** AL, OTC, PHC, QLL, ** AL, OTC, PHC, QLL, ** cyanocobalamin inj 1000 mcg/mL ergocalciferol caps cholecalciferol (vitamin D3) caps, tabs 400 IU ferrous sulfate drops 15 mg/mL ferrous sulfate elixir 220 mg/5 mL Wee Care susp 15 mg/1.25 mL MEPHYTON FERROUS SULFATE syp 300 mg/5 mL GP GP GNP GNP GNP GNP BP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 62 AL, OTC, PHC, QLL, ** MYKIDZ IRON susp 15 mg/1.5 mL BNP * Limited to 400 IU caps, tabs for members age 65 years and older. ** Limited to children through age one. RESPIRATORY Guidelines to the management, prevention, or treatment of COPD and asthma are available at: http://www.aaaai.org http://www.ginasthma.com http://www.goldcopd.com http://www.nhlbi.nih.gov The Allergy Report and guidelines for allergy-related conditions are available at: http://www.aaaai.org ANAPHYLAXIS TREATMENT AGENTS epinephrine EPIPEN EPIPEN JR. GNP BP BP ANTICHOLINERGICS-M ipratropium nasal spray ipratropium soln ATROVENT HFA SPIRIVA INCRUSE ELLIPTA TUDORZA GNP GNP BP BP BNP BNP ANTICHOLINERGIC/BETA AGONIST COMBINATIONS-M Short Acting-M ipratropium/albuterol COMBIVENT RESPIMAT GNP BP PAR PAR Long Acting-M ANORO ELLIPTA ANTIHISTAMINES, LOW SEDATING levocetirizine XYZAL BP GNP BNP PREFERRED ALTERNATIVES XYZAL: OTC cetirizine*, OTC fexofenadine*, OTC loratadine*, levocetirizine * OTC cetirizine, OTC fexofenadine and OTC loratadine are not covered under the prescription drug benefit. ANTIHISTAMINES, NONSEDATING-M desloratadine CLARINEX GNP BNP PREFERRED ALTERNATIVES CLARINEX: OTC cetirizine*, OTC fexofenadine*, OTC loratadine*, desloratadine * OTC cetirizine, OTC fexofenadine and OTC loratadine are not covered under the prescription drug benefit. GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 63 ANTIHISTAMINES, SEDATING hydroxyzine HCl syrup hydroxyzine pamoate caps 25 mg, 50 mg hydroxyzine HCl tabs hydroxyzine pamoate caps 100 mg ANTIHISTAMINE/DECONGESTANT COMBINATIONS promethazine/phenylephrine CLARINEX-D GP GP GNP GNP GNP BNP PREFERRED ALTERNATIVES CLARINEX-D: OTC cetirizine*+decongestant*, OTC fexofenadine*+decongestant*, OTC loratadine*+decongestant* * OTC cetirizine, OTC fexofenadine, OTC loratadine and OTC decongestants are not covered under the prescription drug benefit. ANTITUSSIVES Clinical practice guidelines are available at: http://journal.publications.chestnet.org/article.aspx?articleID=1084267 benzonatate caps 100 mg benzonatate caps 200 mg GP GNP codeine/guaifenesin liquid codeine/promethazine codeine/brompheniramine/pseudoephedrine codeine/promethazine/phenylephrine hydrocodone/chlorpheniramine ext-rel TUSSIONEX GP GP GNP GNP GNP BNP dextromethorphan/promethazine GP albuterol soln levalbuterol PROAIR HFA VENTOLIN HFA PROVENTIL HFA XOPENEX XOPENEX HFA GNP GNP BP BP BNP BNP BNP ANTITUSSIVE COMBINATIONS Opioid Non-opioid BETA AGONISTS-M Inhalants-M Short Acting-M PREFERRED ALTERNATIVES PROVENTIL HFA: PROAIR HFA, VENTOLIN HFA XOPENEX: levalbuterol XOPENEX HFA: PROAIR HFA, VENTOLIN HFA GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 64 Long Acting-M Hand-held Active Inhalation-M SEREVENT ARCAPTA NEOHALER BP BNP albuterol sulfate syrup albuterol tabs GP GNP tobramycin inhalation soln KALYDECO ORKAMBI PULMOZYME BETHKIS TOBI GNP BP BP BP BNP BNP montelukast zafirlukast ACCOLATE SINGULAIR ZYFLO CR GNP GNP BNP BNP BNP Oral Agents-M CYSTIC FIBROSIS SRx PAR, SRx PAR, SRx SRx SRx SRx LEUKOTRIENE MODIFIERS-M PREFERRED ALTERNATIVES ACCOLATE: zafirlukast SINGULAIR: montelukast MAST CELL STABILIZERS-M cromolyn soln GNP azelastine olopatadine ASTEPRO PATANASE GNP GNP BNP BNP NASAL ANTIHISTAMINES PREFERRED ALTERNATIVES ASTEPRO: azelastine PATANASE: olopatadine NASAL ANTIHISTAMINE/STEROID COMBINATIONS EPA DYMISTA BNP PREFERRED ALTERNATIVES DYMISTA: azelastine NASAL STEROIDS-M PAR PAR flunisolide spray mometasone spray BECONASE AQ NASONEX GNP GNP BNP BNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 65 PAR PAR PAR, QLL PAR OMNARIS QNASL VERAMYST ZETONNA BNP BNP BNP BNP PREFERRED ALTERNATIVES BECONASE AQ: OTC FLONASE ALLERGY RELIEF*, OTC NASACORT ALLERGY 24HR*, OTC RHINOCORT ALLERGY*, flunisolide, mometasone NASONEX: OTC FLONASE ALLERGY RELIEF*, OTC NASACORT ALLERGY 24HR*, OTC RHINOCORT ALLERGY*, mometasone OMNARIS: OTC FLONASE ALLERGY RELIEF*, OTC NASACORT ALLERGY 24HR*, OTC RHINOCORT ALLERGY*, flunisolide, mometasone QNASL: OTC FLONASE ALLERGY RELIEF*, OTC NASACORT ALLERGY 24HR*, OTC RHINOCORT ALLERGY*, flunisolide, mometasone VERAMYST: OTC FLONASE ALLERGY RELIEF*, OTC NASACORT ALLERGY 24HR*, OTC RHINOCORT ALLERGY*, flunisolide, mometasone ZETONNA: OTC FLONASE ALLERGY RELIEF*, OTC NASACORT ALLERGY 24HR*, OTC RHINOCORT ALLERGY*, flunisolide, mometasone * OTC FLONASE ALLERGY RELIEF, OTC NASACORT ALLERGY 24HR and OTC RHINOCORT ALLERGY are not covered under the prescription drug benefit. PHOSPHODIESTERASE-4 INHIBITORS DALIRESP BNP PULMONARY FIBROSIS AGENTS PAR, SRx ESBRIET PAR, SRx OFEV BP BP STEROID/BETA AGONIST COMBINATIONS-M QLL ADVAIR DISKUS QLL ADVAIR HFA QLL BREO ELLIPTA QLL DULERA PAR, QLL SYMBICORT BP BP BP BP BNP STEROID INHALANTS-M QLL QLL QLL QLL QLL QLL QLL budesonide inhalation susp ASMANEX FLOVENT ALVESCO ARNUITY ELLIPTA PULMICORT FLEXHALER PULMICORT RESPULES QVAR GNP BP BP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ALVESCO: ASMANEX, FLOVENT ARNUITY ELLIPTA: ASMANEX, FLOVENT PULMICORT FLEXHALER: ASMANEX, FLOVENT PULMICORT RESPULES: budesonide inhalation susp QVAR: ASMANEX, FLOVENT GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 66 XANTHINES-M theophylline ext-rel 12hr tabs 100 mg theophylline GP GNP TOPICAL DERMATOLOGY Acne Guidelines for the care and treatment of acne vulgaris are available at: http://www.aad.org/education-and-quality-care/clinical-guidelines Topical adapalene Avita clindamycin clindamycin/benzoyl peroxide erythromycin erythromycin/benzoyl peroxide sulfacetamide sodium tretinoin tretinoin gel microsphere TAZORAC ACANYA ACZONE ATRALIN AZELEX BENZACLIN DIFFERIN DUAC EPIDUO KLARON RETIN-A MICRO TRETIN-X PAR* PAR* PAR* PAR* EPA PAR* PAR* PAR* GNP GNP GNP GNP GNP GNP GNP GNP GNP BP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP *PAR required for members age 25 and older. PREFERRED ALTERNATIVES ACANYA: clindamycin/benzoyl peroxide ACZONE: clindamycin, erythromycin ATRALIN: tretinoin AZELEX: tretinoin BENZACLIN: clindamycin/benzoyl peroxide DIFFERIN: adapalene DUAC: clindamycin/benzoyl peroxide EPIDUO: adapalene KLARON: sulfacetamide sodium RETIN-A MICRO: tretinoin, tretinoin gel microsphere TRETIN-X: tretinoin Actinic Keratosis fluorouracil crm, soln GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 67 CARAC BNP PREFERRED ALTERNATIVES CARAC: fluorouracil crm Antibiotics mupirocin oint gentamicin crm gentamicin oint mupirocin crm silver sulfadiazine ALTABAX BACTROBAN CENTANY GP GNP GNP GNP GNP BNP BNP BNP PREFERRED ALTERNATIVES ALTABAX: mupirocin BACTROBAN: mupirocin CENTANY: mupirocin Antifungals ciclopirox econazole ketoconazole naftifine nystatin oxiconazole ERTACZO EXELDERM LOPROX LUZU MENTAX NAFTIN OXISTAT PENLAC GNP GNP GNP GNP GNP GNP BNP BNP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES EXELDERM: ketoconazole, econazole, oxiconazole ERTACZO: ketoconazole, econazole, oxiconazole LOPROX: ciclopirox LUZU: ketoconazole, econazole, oxiconazole MENTAX: ketoconazole, econazole, oxiconazole NAFTIN: naftifine OXISTAT: oxiconazole PENLAC: ciclopirox Antifungal/Corticosteroid Combinations clotrimazole/betamethasone nystatin/triamcinolone GNP GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 68 Antipsoriatics Guidelines of care for the management and treatment of psoriasis with topical therapies are available at: http://www.aad.org Injectable PAR, SRx PAR, QLL, SRx COSENTYX STELARA BNP BNP PREFERRED ALTERNATIVES COSENTYX: ENBREL, HUMIRA STELARA: ENBREL, HUMIRA Oral acitretin methoxsalen oral GNP GNP calcipotriene calcipotriene/betamethasone diproprionate oint calcitriol oint DOVONEX TACLONEX VECTICAL GNP GNP GNP BNP BNP BNP Topical PREFERRED ALTERNATIVES DOVONEX: calcipotriene TACLONEX: calcipotriene/betamethasone dipropionate oint VECTICAL: calcitriol oint Antiseborrheics selenium sulfide lotion, shampoo 2.5% GP hydrocortisone crm, oint 2.5% alclometasone crm, oint 0.05% desonide crm, lotion, oint 0.05% fluocinolone acetonide oil 0.01% PRAMOSONE GP GNP GNP GNP BP triamcinolone acetonide crm, oint 0.1%, 0.025% clocortolone crm 0.1% desoximetasone crm, oint 0.05% fluticasone propionate crm, lotion 0.05%, oint 0.005% hydrocortisone butyrate crm, oint, soln 0.1% hydrocortisone valerate crm, oint 0.2% mometasone crm, lotion, oint 0.1% triamcinolone acetonide crm, oint 0.5% triamcinolone acetonide lotion GP GNP GNP GNP GNP GNP GNP GNP GNP Corticosteroids Low Potency Medium Potency GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 69 LOCOID BNP PREFERRED ALTERNATIVES LOCOID: hydrocortisone butyrate High Potency betamethasone dipropionate augmented crm, lotion 0.05% betamethasone dipropionate crm, lotion, oint 0.05% desoximetasone crm, oint 0.25%, gel 0.05% diflorasone diacetate crm 0.05% fluocinonide crm, gel, oint, soln 0.05% triamcinolone acetonide crm 0.5% GNP GNP GNP GNP GNP GNP betamethasone dipropionate augmented gel, oint 0.05% clobetasol propionate crm, foam, gel, lotion, oint, shampoo, soln, spray 0.05% diflorasone diacetate oint 0.05% GNP GNP Very High Potency GNP Immunomodulators Guidelines for the treatment of atopic dermatitis are available at: http://www.aad.org/education/clinical-guidelines tacrolimus ELIDEL PROTOPIC GNP BP BNP PREFERRED ALTERNATIVES PROTOPIC: tacrolimus Local Analgesics lidocaine patch LIDODERM GNP BNP PREFERRED ALTERNATIVES LIDODERM: lidocaine patch Local Anesthetics lidocaine gel, soln lidocaine crm, lotion lidocaine/prilocaine SYNERA GP GNP GNP BNP PREFERRED ALTERNATIVES EMLA: lidocaine/prilocaine SYNERA: lidocaine/prilocaine Rosacea doxycycline monohydrate metronidazole crm, gel, lotion FINACEA SOOLANTRA GNP GNP BP BP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 70 PAR PAR PAR METROCREAM METROGEL NORITATE ORACEA BNP BNP BNP BNP PREFERRED ALTERNATIVES METROCREAM: metronidazole crm, gel, lotion METROGEL: metronidazole crm, gel, lotion NORITATE: metronidazole crm, gel, lotion ORACEA: doxycycline monohydrate Scabicides and Pediculicides malathion permethrin spinosad NATROBA Miscellaneous Skin and Mucous Membrane aluminum chloride soln 20% acyclovir oint imiquimod podofilox CONDYLOX gel ALDARA CONDYLOX soln PRUMYX SALKERA ZOVIRAX crm ZOVIRAX oint GNP GNP GNP BNP GP GNP GNP GNP BP BNP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ALDARA: imiquimod CONDYLOX soln: podofilox SALKERA: salicylic acid ZOVIRAX oint: acyclovir oint MOUTH/THROAT/DENTAL AGENTS Anesthetics - Topical Oral lidocaine viscous GP Miscellaneous AL, PHC, QLL, * AL, PHC, QLL, * AL, PHC, QLL, * AL, PHC, QLL, * AL, PHC, QLL, * chlorhexidine gluconate sodium fluoride 1 mg (2.2 mg) tabs sodium fluoride chew tabs sodium fluoride paste 1.1% sodium fluoride/potassium nitrate paste 1.1-5% sodium fluoride 0.5 mg (1.1 mg) tabs sodium fluoride soln 0.125 mg/drop F (from 0.275 mg/drop NaF) sodium fluoride soln 0.25 mg/drop F (from 0.55 mg/drop NaF), 0.5 mg/mL F (from 1.1 mg/mL NaF) GP GP GP GP GP GNP GNP GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 71 PREVIDENT BNP * Limited to children through age 18. Over-the-counter products are excluded even with a prescription. PREFERRED ALTERNATIVES PREVIDENT: sodium fluoride OPHTHALMIC Preferred Practice Pattern Guidelines for the treatment of various ophthalmic conditions are available at: http://one.aao.org Antiallergics cromolyn sodium azelastine epinastine olopatadine EMADINE ALOCRIL ALOMIDE ELESTAT LASTACAFT PATANOL GP GNP GNP GNP BP BNP BNP BNP BNP BNP PREFERRED ALTERNATIVES ALOCRIL: cromolyn ALOMIDE: cromolyn ELESTAT: OTC ZADITOR*, epinastine PATANOL: OTC ZADITOR*, olopatadine * OTC ZADITOR is not covered under the prescription drug benefit. Anti-infectives ciprofloxacin erythromycin gentamicin soln ofloxacin polymyxin B/trimethoprim tobramycin gentamicin oint levofloxacin sulfacetamide oint 10% sulfacetamide soln 10% BESIVANCE CILOXAN VIGAMOX GP GP GP GP GP GP GNP GNP GNP GNP BNP BNP BNP PREFERRED ALTERNATIVES BESIVANCE: ciprofloxacin, ofloxacin CILOXAN: ciprofloxacin VIGAMOX: ciprofloxacin, ofloxacin GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 72 Anti-infective/Anti-inflammatory Combinations neomycin/polymyxin B/dexamethasone tobramycin/dexamethasone susp 0.3%/0.1% TOBRADEX oint TOBRADEX susp ZYLET GNP GNP BP BNP BNP PREFERRED ALTERNATIVES TOBRADEX susp: tobramycin/dexamethasone susp Anti-inflammatories Nonsteroidal bromfenac sodium diclofenac sodium fluorometholone 0.1% susp ketorolac ACULAR ACULAR LS ACUVAIL GNP GNP GNP GNP BNP BNP BNP PREFERRED ALTERNATIVES ACUVAIL: ketorolac Steroidal prednisolone acetate ALREX LOTEMAX FML FORTE VEXOL GNP BP BP BNP BNP PREFERRED ALTERNATIVES FML FORTE: ALREX, LOTEMAX VEXOL: ALREX, LOTEMAX Beta-blockers-M Nonselective-M timolol maleate soln levobunolol soln timolol maleate gel BETIMOL GP GNP GNP BNP PREFERRED ALTERNATIVES BETIMOL: timolol Carbonic Anhydrase Inhibitors-M Topical-M dorzolamide AZOPT TRUSOPT GNP BP BNP PREFERRED ALTERNATIVES TRUSOPT: dorzolamide GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 73 Carbonic Anhydrase Inhibitor/Beta-blocker Combinations-M dorzolamide/timolol COSOPT GNP BNP PREFERRED ALTERNATIVES COSOPT: dorzolamide/timolol Immunomodulators-M RESTASIS BNP pilocarpine GNP bimatoprost latanoprost travoprost LUMIGAN TRAVATAN Z XALATAN ZIOPTAN GNP GNP GNP BP BP BNP BNP Parasympathomimetics-M Prostaglandins-M PREFERRED ALTERNATIVES XALATAN: latanoprost ZIOPTAN: bimatoprost, latanoprost, travoprost, LUMIGAN, TRAVATAN Z Sympathomimetics-M brimonidine 0.2% brimonidine 0.15% ALPHAGAN P GP GNP BP OTIC Clinical practice guidelines for the treatment of otitis media are available at: http://www.aap.org Anti-infectives ofloxacin otic Anti-infective/Anti-inflammatory Combinations acetic acid/hydrocortisone CIPRODEX CIPRO HC OTIC GNP GNP BP BNP PREFERRED ALTERNATIVES CIPRO HC OTIC: CIPRODEX Miscellaneous fluocinolone acetonide oil GNP GP = Generic Preferred GNP = Generic Non-Preferred BP = Brand Preferred BNP = Brand Non-Preferred AL = Age Limitations apply EPA = Enhanced Prior Authorization applies M = Maintenance Drugs OTC = Over-The-Counter medication PAR = Prior Authorization Required PHC = Preventive Health Care QLL = Quantity Level Limits apply SRx = Specialty Drug available from Accredo 74 WEBSITES Agency for Healthcare Research and Quality http://www.ahrq.gov Alzheimer's Association http://www.alz.org American Academy of Allergy, Asthma and Immunology http://www.aaaai.org American Academy of Child & Adolescent Psychiatry http://www.aacap.org American Academy of Dermatology http://www.aad.org American Academy of Neurology http://www.aan.com American Academy of Ophthalmology http://www.aao.org American Academy of Pediatrics http://www.aap.org American Association for the Study of Liver Disease http://www.aasld.org American Association of Clinical Endocrinologists http://www.aace.com American Association of Diabetes Educators http://www.diabeteseducator.org American Cancer Society http://www.cancer.org American College of Allergy, Asthma and Immunology http://www.acaai.org American College of Cardiology http://www.acc.org American College of Chest Physicians http://www.chestnet.org American Congress of Obstetricians and Gynecologists http://www.acog.org American Diabetes Association http://www.diabetes.org American Gastroenterological Association http://www.gastro.org American Headache Society Committee for Headache Education http://www.achenet.org American Heart Association http://www.myamericanheart.org American Lung Association http://www.lung.org American Medical Association http://www.ama-assn.org American Psychiatric Association http://www.psych.org American Society of Anesthesiologists http://www.asahq.org American Society of Clinical Oncology http://www.asco.org American Society of Interventional Pain Physicians http://www.asipp.org American Urological Association http://www.auanet.org Centers for Disease Control and Prevention http://www.cdc.gov Centers for Disease Control and Prevention Guideline topics: AIDS http://www.cdc.gov/hiv/default.html American College of Gastroenterology http://gi.org Centers for Disease Control and Prevention Guideline topics: Sexually Transmitted Diseases http://www.cdc.gov/std/treatment/default.htm American College of Physicians http://www.acponline.org CVS Caremark http://www.caremark.com American College of Rheumatology http://www.rheumatology.org The Food and Drug Administration http://www.fda.gov 75 Global Initiative for Asthma http://www.ginasthma.com National Foundation for Infectious Diseases http://www.nfid.org Infectious Diseases Society of America http://www.idsociety.org National Guideline Clearinghouse http://www.guideline.gov Institute for Safe Medication Practices http://www.ismp.org National Heart, Lung and Blood Institute http://www.nhlbi.nih.gov Johns Hopkins AIDS Service http://www.thebody.com/content/art12096.html National Institutes of Health http://www.nih.gov Juvenile Diabetes Research Foundation International http://jdrf.org National Kidney Foundation http://www.kidney.org MedWatch http://www.fda.gov/Safety/MedWatch/default.htm National Osteoporosis Foundation http://www.nof.org National Agricultural Library http://www.nal.usda.gov North American Menopause Society http://www.menopause.org National Cancer Institute http://www.cancer.gov/cancertopics United States Department of Health and Human Services http://www.hhs.gov National Comprehensive Cancer Network http://www.nccn.org World Health Organization http://www.who.int 76 INDEX A abacavir tabs, 18 abacavir/lamivudine/zidovudine, 17 ABILIFY, 35 ABSTRAL, 13 ACANYA, 67 acarbose, 41 ACCOLATE, 65 ACCU-CHEK, 45 ACCUPRIL, 22 ACEON, 22 acetic acid/hydrocortisone, 74 ACIPHEX, 56 acitretin, 69 ACTEMRA 162 mg/0.9 mL, 60 ACTHAR HP, 53 ACTIMMUNE, 61 ACTIQ, 13 ACTIVELLA, 50 ACTONEL, 46 ACTOPLUS MET, 43 ACTOPLUS MET XR, 43 ACTOS, 43 ACULAR, 73 ACULAR LS, 73 ACUVAIL, 73 acyclovir caps 200 mg, 19 acyclovir oint, 71 acyclovir tabs 400 mg, 800 mg, 19 ACZONE, 67 adapalene, 67 ADCIRCA, 29 ADDERALL, 36 ADDERALL XR, 37 ADEMPAS, 30 ADOXA, 16 ADVAIR DISKUS, 66 ADVAIR HFA, 66 ADVATE, 58 AFINITOR, 21 AFREZZA, 43 AGGRENOX, 60 AKYNZEO, 54 albuterol soln, 64 albuterol sulfate syrup, 65 albuterol tabs, 65 alclometasone crm, oint 0.05%, 69 ALDARA, 71 ALECENSA, 21 alendronate soln, 46 alendronate tabs 40 mg, 46 alendronate tabs 5 mg, 35 mg, 70 mg, 45 alfuzosin ext-rel, 56 allopurinol, 12 almotriptan, 38 ALOCRIL, 72 alogliptin, 42 alogliptin/metformin, 42 alogliptin/pioglitazone, 42 ALOMIDE, 72 ALORA, 49 ALPHAGAN P, 74 ALPHANATE, 58 ALPHANINE SD, 58 alprazolam, 30 alprazolam ext-rel, 30 alprazolam orally disintegrating tabs, 30 ALREX, 73 ALTABAX, 68 ALTACE, 22 ALTOPREV, 26 aluminum chloride soln 20%, 71 ALVESCO, 66 amantadine, 35 AMARYL, 44 AMBIEN, 38 AMBIEN CR, 38 AMERGE, 38 Amethia, 48 Amethia Lo, 48 amiloride, 29 amiloride/hydrochlorothiazide, 29 amiodarone tabs 100 mg, 400 mg, 25 amiodarone tabs 200 mg, 25 AMITIZA, 55 amitriptyline 10 mg, 25 mg, 50 mg, 75 mg, 150 mg, 34 amitriptyline 100 mg, 34 amlodipine, 27 amlodipine/atorvastatin, 28 amlodipine/benazepril, 23 amlodipine/valsartan, 24 amlodipine/valsartan/hydrochlorothiazide, 25 amoxicillin caps, susp, tabs, 16 amoxicillin chewable tabs, 16 amoxicillin ext-rel, 16 amoxicillin/clavulanate, 16 amoxicillin/clavulanate ext-rel, 16 amphetamine/dextroamphetamine mixed salts, 36 amphetamine/dextroamphetamine mixed salts ext-rel, 36 ampicillin caps 250 mg, 16 ampicillin caps 500 mg, 16 ampicillin susp, 16 AMPYRA, 39 AMRIX, 40 anagrelide, 60 anastrozole, 20 ANDRODERM, 41 ANDROGEL 1% (25 mg), 41 ANDROGEL 1% (50 mg), 1.62%, 41 ANDROGEL PUMP 1%, 41 ANORO ELLIPTA, 63 ANTARA, 25 ANZEMET, 54 APIDRA, 43 APLENZIN, 34 APOKYN, 35 Apri, 47 APRISO, 54 APTIOM, 31 APTIVUS, 18 Aranelle, 47 ARANESP, 59 ARCALYST, 61 ARCAPTA NEOHALER, 65 ARICEPT, 32 77 ARIMIDEX, 20 aripiprazole, 35 ARIXTRA, 58 armodafinil, 40 ARNUITY ELLIPTA, 66 ASACOL HD, 54 ASCENSIA, 45 ASMANEX, 66 aspirin 81 mg, 162 mg, 325 mg, 60 aspirin chew tabs, 60 aspirin delayed-rel 81 mg, 162 mg, 325 mg, 60 ASTEPRO, 65 ATACAND, 24 ATACAND HCT, 24 ATELVIA, 46 atenolol, 27 atenolol/chlorthalidone, 27 atorvastatin, 26 atovaquone/proguanil, 17 ATRALIN, 67 ATRIPLA, 17 ATROVENT HFA, 63 AUBAGIO, 39 AVALIDE, 24 AVAPRO, 24 AVELOX, 15 AVELOX ABC PACK, 15 Aviane, 46 AVIDOXY, 16 Avita, 67 AVODART, 56 AVONEX, 39 AXERT, 38 AXIRON, 41 azathioprine, 61 azelastine, 65, 72 AZELEX, 67 azithromycin susp, 15 azithromycin tabs 250 mg, 15 azithromycin tabs 500 mg, 600 mg, 15 AZOPT, 73 AZOR, 24 B baclofen tabs, 39 BACTROBAN, 68 balsalazide, 54 BANZEL, 31 BARACLUDE, 18 BEBULIN VH, 58 BECONASE AQ, 65 BELSOMRA, 38 BELVIQ, 45 benazepril, 22 benazepril/hydrochlorothiazide, 23 BENEFIX, 59 BENICAR, 24 BENICAR HCT, 24 BENZACLIN, 67 benzonatate caps 100 mg, 64 benzonatate caps 200 mg, 64 benztropine, 35 BERINERT, 59 BESIVANCE, 72 betamethasone dipropionate augmented crm, lotion 0.05%, 70 betamethasone dipropionate augmented gel, oint 0.05%, 70 betamethasone dipropionate crm, lotion, oint 0.05%, 70 BETASERON, 39 BETHKIS, 65 BETIMOL, 73 bexarotene, 22 BIAXIN, 15 bicalutamide, 20 BIDIL, 29 bimatoprost, 74 bisoprolol, 27 bisoprolol/hydrochlorothiazide, 27 BONIVA tabs, 46 BOSULIF, 21 BRAVELLE, 50 BREEZE, 45 BREO ELLIPTA, 66 brimonidine 0.15%, 74 brimonidine 0.2%, 74 BRINTELLIX, 33 bromfenac sodium, 73 bromocriptine, 35 budesonide delayed-rel caps, 54 budesonide inhalation susp, 66 bumetanide, 28 buprenorphine/naloxone sublingual tabs, 40 bupropion, 34 bupropion ext-rel, 34, 40 buspirone tabs 5 mg, 10 mg, 15 mg, 30 buspirone tabs 7.5 mg, 30 mg, 30 butalbital/acetaminophen/caffeine caps, tabs, 14 butalbital/aspirin/caffeine caps, tabs, 14 butorphanol nasal spray, 12 BUTRANS, 13 BYDUREON, 42 BYETTA, 42 BYSTOLIC, 27 C CADUET, 28 calcipotriene, 69 calcipotriene/betamethasone diproprionate oint, 69 calcitonin-salmon, 46 calcitriol, 51 calcitriol oint, 69 calcium acetate, 52 Camila, 48 Camrese, 48 Camrese Lo, 48 CANASA, 55 candesartan, 24 candesartan/hydrochlorothiazide, 24 capecitabine, 20 CAPRELSA, 21 captopril, 22 captopril/hydrochlorothiazide, 23 CARAC, 68 CARBAGLU, 56 carbamazepine chews, tabs, 30 carbamazepine ext-rel, 31 carbamazepine susp, 31 CARBATROL, 31 carbidopa/levodopa, 35 carbidopa/levodopa orally disintegrating tabs, 35 carbidopa/levodopa/entacapone, 35 CARDIZEM, 28 CARDIZEM CD, 28 CARDIZEM LA, 28 carisoprodol tabs 250 mg, 39 carisoprodol tabs 350 mg, 39 carvedilol, 27 CASODEX, 20 CATAPRES-TTS, 23 CAVERJECT, 57 CEDAX, 15 cefaclor, 14 cefadroxil, 14 cefdinir, 15 cefditoren, 15 cefixime susp 100 mg/5 mL, 200 mg/5 mL, 15 cefpodoxime, 15 cefprozil, 14 ceftibuten, 15 CEFTIN, 14 cefuroxime axetil tabs, 14 CELEBREX, 12 celecoxib, 12 CELEXA, 33 CELLCEPT, 62 CENTANY, 68 cephalexin caps 250 mg, 500 mg, 14 cephalexin susp, 14 cephalexin tabs 250 mg, 14 CESAMET, 54 CETROTIDE, 50 CHANTIX, 40 chlorhexidine gluconate, 71 chlorthalidone, 29 chlorzoxazone, 40 CHOLBAM, 56 cholecalciferol (vitamin D3) caps, tabs 400 IU, 62 cholestyramine, 25 chorionic gonadotropin - Novarel, 50 chorionic gonadotropin - Pregnyl, 50 CIALIS 10 mg, 20 mg, 57 CIALIS 2.5 mg, 5 mg, 57 ciclopirox, 68 cilostazol, 60 CILOXAN, 72 cimetidine 300 mg, 400 mg, 800 mg, 54 CIMZIA, 60 CIPRO HC OTIC, 74 CIPRODEX, 74 ciprofloxacin, 15, 72 ciprofloxacin ext-rel, 15 citalopram soln, 33 citalopram tabs, 33 CLARINEX, 63 CLARINEX-D, 64 clarithromycin, 15 clarithromycin ext-rel, 15 CLIMARA, 49 CLIMARA PRO, 50 clindamycin, 67 clindamycin caps 150 mg, 300 mg, 19 clindamycin/benzoyl peroxide, 67 clobetasol propionate crm, foam, gel, lotion, oint, shampoo, soln, spray 0.05%, 70 clocortolone crm 0.1%, 69 clomiphene, 50 clonazepam orally disintegrating tabs, 30 clonazepam tabs, 30 clonidine, 23 clonidine ext-rel, 36 clonidine transdermal, 23 clopidogrel, 60 clotrimazole troches, 16 clotrimazole/betamethasone, 68 clozapine, 35 COARTEM, 17 codeine sulfate tabs 15 mg, 12 codeine/acetaminophen soln, 12 codeine/acetaminophen tabs 300/15 mg, 300/30 mg, 12 codeine/acetaminophen tabs 300/60 mg, 12 codeine/brompheniramine/pseudoephedrine, 64 codeine/guaifenesin liquid, 64 codeine/promethazine, 64 codeine/promethazine/phenylephrine, 64 COLAZAL, 54 colchicine, 12 COLCRYS, 12 colestipol, 25 COMBIPATCH, 50 COMBIVENT RESPIMAT, 63 COMETRIQ, 21 COMPLERA, 17 COMTAN, 35 CONCERTA, 37 CONDYLOX gel, 71 CONDYLOX soln, 71 CONTOUR, 45 CONTRAVE, 45 COPAXONE 20 mg, 39 COPAXONE 40 mg, 39 COPEGUS, 19 COREG, 27 COREG CR, 27 CORIFACT, 59 CORLANOR, 30 COSENTYX, 69 COSOPT, 74 COTELLIC, 21 COUMADIN, 58 COZAAR, 24 CREON, 55 CRESEMBA, 16 CRESTOR, 26 CRIXIVAN, 18 cromolyn sodium, 72 cromolyn sodium oral concentrate, 56 cromolyn soln, 65 Cryselle, 47 cyanocobalamin inj 1000 mcg/mL, 62 CYCLESSA, 48 cyclobenzaprine tabs 5 mg, 10 mg, 39 cyclobenzaprine tabs 7.5 mg, 40 cyclosporine, 62 cyclosporine, modified, 62 CYMBALTA, 33 CYSTADANE, 60 CYSTAGON, 53 CYTOMEL, 53 D DALIRESP, 66 darifenacin ext-rel, 57 DAYTRANA, 37 DDAVP, 53 DELZICOL, 54 DEMADEX, 28 DENAVIR, 19 DEPAKOTE, 31 DEPAKOTE ER, 31 DEPO-PROVERA, 49 desipramine, 34 desloratadine, 63 desmopressin, 53 DESOGEN, 47 desonide crm, lotion, oint 0.05%, 69 desoximetasone crm, oint 0.05%, 69 desoximetasone crm, oint 0.25%, gel 0.05%, 70 DESVENLAFAXINE ER, 33 DETROL, 57 DETROL LA, 57 dexamethasone tabs 0.5 mg, 0.75 mg, 1 mg, 1.5 mg, 4 mg, 6 mg, 51 dexamethasone tabs 2 mg, 51 DEXILANT, 55 dexmethylphenidate, 36 dexmethylphenidate ext-rel, 36 dextroamphetamine, 36 dextromethorphan/promethazine, 64 diazepam, 30 diazepam rectal gel, 31 diclofenac potassium, 11 diclofenac sodium, 73 diclofenac sodium delayed-rel, 11 diclofenac sodium soln, 11 dicyclomine caps, tabs, 54 dicyclomine soln, 54 didanosine delayed-rel, 18 DIFFERIN, 67 DIFICID, 15 diflorasone diacetate crm 0.05%, 70 diflorasone diacetate oint 0.05%, 70 DIFLUCAN, 17 diflunisal, 11 digoxin, 28 DILANTIN, 31 DILANTIN INFATABS, 31 diltiazem 30 mg, 60 mg, 120 mg, 28 diltiazem 90 mg, 28 diltiazem ext-rel, 28 DIOVAN, 24 DIOVAN HCT, 24 DIPENTUM, 55 diphenoxylate/atropine, 53 dipyridamole, 60 dipyridamole ext-rel/aspirin, 60 DITROPAN XL, 57 divalproex sodium delayed-rel tabs 125 mg, 31 divalproex sodium delayed-rel tabs 250 mg, 500 mg, 31 divalproex sodium ext-rel, 31 donepezil, 32 donepezil orally disintegrating tabs, 32 DORYX, 16 dorzolamide, 73 dorzolamide/timolol, 74 DOVONEX, 69 doxazosin, 24 doxepin caps 10 mg, 34 doxepin caps 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 34 doxepin oral concentrate, 34 doxercalciferol, 51 doxycycline hyclate caps 50 mg, 100 mg, 16 doxycycline hyclate tabs 20 mg, 100 mg, 16 doxycycline monohydrate, 16, 70 DUAC, 67 DUAVEE, 50 DUET DHA, 62 DUETACT, 44 DUEXIS, 11 DULERA, 66 duloxetine delayed-rel, 33 DURAGESIC, 13 dutasteride, 56 dutasteride/tamsulosin, 56 DUTOPROL, 27 DYANAVEL XR, 37 DYMISTA, 65 E econazole, 68 EDARBI, 24 EDEX, 57 EDLUAR, 38 EDURANT, 17 EFFEXOR XR, 34 EFFIENT, 60 EGRIFTA, 53 ELESTAT, 72 ELIDEL, 70 ELIGARD, 21 ELIQUIS, 58 ELLA, 48 ELMIRON, 58 EMADINE, 72 EMEND, 54 EMSAM, 34 EMTRIVA, 18 ENABLEX, 57 enalapril, 22 enalapril/hydrochlorothiazide, 23 ENBREL, 60 enoxaparin, 58 Enpresse, 47 entacapone, 35 entecavir, 18 ENTRESTO, 29 EPIDUO, 67 epinastine, 72 epinephrine, 63 EPIPEN, 63 EPIPEN JR., 63 EPIVIR-HBV, 18 eplerenone, 23 EPOGEN, 59 eprosartan, 24 EPZICOM, 17 ergocalciferol caps, 62 ERIVEDGE, 22 Errin, 48 ERTACZO, 68 erythromycin, 15, 67, 72 erythromycin ethylsuccinate, 15 erythromycin/benzoyl peroxide, 67 ESBRIET, 66 escitalopram, 33 esomeprazole delayed-rel, 55 estradiol, 49 estradiol/norethindrone, 50 ESTRING, 50 ESTROGEL, 49 estropipate 0.75 mg, 3 mg, 49 estropipate 1.5 mg, 49 ESTROSTEP FE, 48 eszopiclone, 38 ethambutol, 18 etodolac, 11 EVISTA, 52 EVOTAZ, 17 EVZIO, 40 EXELDERM, 68 EXELON, 32 EXFORGE, 25 EXFORGE HCT, 25 EXJADE, 60 EXTAVIA, 39 F FACTIVE, 15 famciclovir, 19 famotidine 40 mg, 54 FAMVIR, 19 FANAPT, 35 FARXIGA, 44 FARYDAK, 22 FAST TAKE, 45 FEIBA NF, 59 FEIBA VH, 59 felodipine ext-rel, 27 FEMARA, 20 FEMHRT 0.5 mg/2.5 mcg, 50 fenofibrate, 25 fenofibric acid delayed-rel, 25 fentanyl patches, 12 fentanyl transmucosal lozenges, 12 FENTORA, 13 FERRIPROX, 60 ferrous sulfate drops 15 mg/mL, 62 ferrous sulfate elixir 220 mg/5 mL, 62 FERROUS SULFATE syp 300 mg/5 mL, 62 FETZIMA, 34 FINACEA, 70 finasteride, 56 FIRAZYR, 60 FIRMAGON, 20 flecainide, 25 FLECTOR, 11 FLOMAX, 56 FLOVENT, 66 fluconazole susp, 16 fluconazole tabs 100 mg, 200 mg, 16 fluconazole tabs 50 mg, 150 mg, 16 fludrocortisone, 51 flunisolide spray, 65 fluocinolone acetonide oil, 74 fluocinolone acetonide oil 0.01%, 69 fluocinonide crm, gel, oint, soln 0.05%, 70 fluorometholone 0.1% susp, 73 fluorouracil crm, soln, 67 fluoxetine caps 10 mg, 20 mg, 33 fluoxetine caps 40 mg, 33 fluoxetine delayed-rel, 33 fluoxetine soln, 33 fluoxetine tabs 10 mg, 33 fluoxetine tabs 20 mg, 33 flurazepam caps 15 mg, 37 flurazepam caps 30 mg, 37 fluticasone propionate crm, lotion 0.05%, oint 0.005%, 69 fluvastatin, 26 fluvastatin ext-rel, 26 fluvoxamine, 30 FML FORTE, 73 FOCALIN, 37 FOCALIN XR, 37 folic acid tabs 0.4 mg, 0.8 mg, 62 folic acid tabs 1 mg, 62 FOLLISTIM AQ, 50 fondaparinux, 58 FORTAMET, 41 FORTEO, 46 FORTESTA, 41 FOSAMAX, 46 FOSAMAX PLUS D, 46 fosinopril, 22 fosinopril/hydrochlorothiazide, 23 FOSRENOL, 52 FRAGMIN, 58 FREESTYLE, 45 FROVA, 38 frovatriptan, 38 FULYZAQ, 53 furosemide, 28 FUZEON, 17 FYCOMPA, 31 G gabapentin caps 100 mg, 31 gabapentin caps 300 mg, 400 mg, 31 gabapentin tabs, soln, 31 galantamine, 32 galantamine ext-rel, 32 GANIRELIX, 50 GATTEX, 56 GELNIQUE, 57 gemfibrozil, 25 GENOTROPIN, 51 gentamicin crm, 68 gentamicin oint, 68, 72 gentamicin soln, 72 GEODON, 35 Gianvi, 46 GILENYA, 39 GILOTRIF, 21 glatiramer, 39 GLEEVEC, 21 glimepiride, 44 glipizide, 44 glipizide ext-rel tabs 10 mg, 44 glipizide ext-rel tabs 2.5 mg, 5 mg, 44 glipizide/metformin, 42 GLUCAGEN, 51 GLUCAGON, 51 GLUCOPHAGE XR, 41 GLUCOVANCE, 42 GLUMETZA, 41 glyburide micronized, 44 glyburide tabs 1.25 mg, 2.5 mg, 44 glyburide tabs 5 mg, 44 glyburide/metformin tabs 1.25/250 mg, 42 glyburide/metformin tabs 2.5/500 mg, 5/500 mg, 42 GLYSET, 41 GOLYTELY, 55 GONAL-F, 50 GONAL-F RFF, 50 granisetron, 53 GRANIX, 59 griseofulvin ultramicrosize, 16 guanfacine ext-rel, 36 guanfacine tabs 1 mg, 23 guanfacine tabs 2 mg, 23 GYNOL II GEL 3%, 49 H haloperidol oral concentrate, 36 haloperidol tabs, 36 HARVONI, 19 HECTOROL, 51 HELIXATE FS, 59 HEMOFIL M, 59 HETLIOZ, 38 HIZENTRA, 61 HORIZANT, 40 HUMALOG, 43 HUMALOG MIX, 43 HUMATE-P, 59 HUMATROPE, 51 HUMIRA, 60 HUMULIN 70/30, 43 HUMULIN N, 43 HUMULIN R, 43 HYCAMTIN caps, 22 hydralazine tabs 10 mg, 30 hydralazine tabs 25 mg, 50 mg, 100 mg, 30 hydrochlorothiazide caps, 29 hydrochlorothiazide tabs 12.5 mg, 29 hydrochlorothiazide tabs 25 mg, 50 mg, 29 hydrocodone/acetaminophen caps, 12 hydrocodone/acetaminophen soln 7.5/325 mg/15 mL, 12 hydrocodone/acetaminophen tabs 2.5/325 mg, 5/300 mg, 7.5/300 mg, 7.5/325 mg, 10/300 mg, 10/325 mg, 12 hydrocodone/acetaminophen tabs 5/325 mg, 12 hydrocodone/chlorpheniramine ext-rel, 64 hydrocodone/ibuprofen, 12 hydrocortisone, 51 hydrocortisone butyrate crm, oint, soln 0.1%, 69 hydrocortisone crm, oint 2.5%, 69 hydrocortisone rectal crm, 56 hydrocortisone valerate crm, oint 0.2%, 69 hydromorphone ext-rel, 12 hydromorphone soln, supp, 12 hydromorphone tabs 2 mg, 12 hydromorphone tabs 4 mg, 8 mg, 13 hydroxychloroquine, 61 hydroxyzine HCl syrup, 64 hydroxyzine HCl tabs, 64 hydroxyzine pamoate caps 100 mg, 64 hydroxyzine pamoate caps 25 mg, 50 mg, 64 hyoscyamine sulfate, 54 HYQVIA, 61 HYZAAR, 24 I ibandronate tabs, 46 IBRANCE, 21 ibuprofen, 11 ICLUSIG, 21 imatinib mesylate, 21 IMBRUVICA, 21 imipramine HCl tabs 10 mg, 34 imipramine HCl tabs 25 mg, 50 mg, 34 imipramine pamoate, 34 imiquimod, 71 IMITREX, 38 INCRELEX, 52 INCRUSE ELLIPTA, 63 indapamide, 29 INDERAL LA, 27 indomethacin, 11 INLYTA, 21 INSPRA, 23 INTELENCE, 17 INTERMEZZO, 38 INTRON A, 61 Introvale, 48 INTUNIV, 37 INVEGA, 35 INVIRASE, 18 INVOKAMET, 44 INVOKANA, 44 ipratropium nasal spray, 63 ipratropium soln, 63 ipratropium/albuterol, 63 irbesartan, 24 irbesartan/hydrochlorothiazide, 24 Irenka, 33 IRESSA, 21 ISENTRESS, 17 isoniazid syrup, 18 isoniazid tabs 100 mg, 18 isoniazid tabs 300 mg, 18 isosorbide dinitrate, 29 isosorbide mononitrate, 29 isosorbide mononitrate ext-rel tabs 30 mg, 29 isosorbide mononitrate ext-rel tabs 60 mg, 120 mg, 29 isradipine, 27 itraconazole, 16 ivermectin, 19 IXINITY, 59 J JADENU, 60 JAKAFI, 21 JALYN, 56 JANUMET, 42 JANUMET XR, 42 JANUVIA, 42 JARDIANCE, 44 JENTADUETO, 42 Jinteli, 50 Jolessa, 48 Jolivette, 48 Junel Fe, 46, 47 JUXTAPID, 27 K KADIAN, 13 KALETRA, 18 KALYDECO, 65 KAPVAY, 37 Kariva, 47 KAZANO, 42 Kelnor 1/35, 47 KEPPRA, 31 KEPPRA XR, 31 ketoconazole, 68 ketoprofen, 11 ketorolac, 73 KHEDEZLA, 34 KINERET, 60 KLARON, 67 KOATE-DVI, 59 KOGENATE FS, 59 KOMBIGLYZE XR, 42 KORLYM, 53 KRISTALOSE, 55 KUVAN, 52 KYNAMRO, 27 L labetalol, 27 lactulose, 55 LAMICTAL, 31 LAMICTAL ODT, 31 LAMICTAL XR, 31 LAMISIL, 17 lamivudine, 18 lamivudine/zidovudine, 17 lamotrigine ext-rel, 31 lamotrigine orally disintegrating tabs, 31 lamotrigine tabs 25 mg, 100 mg, 150 mg, 200 mg, 31 lamotrigine tabs 50 mg, 31 LANOXIN, 28 lansoprazole + amoxicillin + clarithromycin, 56 lansoprazole delayed-rel, 55 LANTUS, 43 LASIX, 28 LASTACAFT, 72 latanoprost, 74 LATUDA, 36 LAZANDA, 13 LENVIMA, 21 LESCOL XL, 26 Lessina, 46 LETAIRIS, 29 letrozole, 20 leucovorin 10 mg, 15 mg, 25 mg, 20 leucovorin 5 mg, 20 LEUKINE, 59 leuprolide acetate, 21 levalbuterol, 64 LEVAQUIN, 15 LEVEMIR, 43 levetiracetam, 31 levetiracetam ext-rel, 31 LEVITRA, 57 levobunolol soln, 73 levocetirizine, 63 levofloxacin, 15, 72 levonorgestrel, 48 levonorgestrel/EE 0.1/20 and EE 10, 48 Levora, 47 levothyroxine sodium 175 mcg, 200 mcg, 300 mcg, 52 levothyroxine sodium 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg, 52 Levoxyl, 52 LEXAPRO, 33 LEXIVA, 18 LIALDA, 54 lidocaine crm, lotion, 70 lidocaine gel, soln, 70 lidocaine patch, 70 lidocaine viscous, 71 lidocaine/prilocaine, 70 LIDODERM, 70 linezolid, 19 LINZESS, 55 liothyronine, 52 LIPITOR, 26 lisinopril, 22 lisinopril/hydrochlorothiazide, 23 lithium carbonate caps, tabs, 39 lithium carbonate ext-rel caps 300 mg, 39 LITHIUM SOLN, 39 LIVALO, 26 LOCOID, 70 LOESTRIN 1.5/30, 47 LOESTRIN 1/20, 46 LOESTRIN FE 1.5/30, 47 LOESTRIN FE 1/20, 46 LOFIBRA, 25 Lomedia 24 Fe, 46 LONSURF, 22 LOPROX, 68 lorazepam oral concentrate, 30 lorazepam tabs, 30 losartan, 24 losartan/hydrochlorothiazide, 24 LOSEASONIQUE, 48 LOTEMAX, 73 LOTREL, 23 lovastatin, 26 LOVAZA, 26 LOVENOX, 58 Low-Ogestrel, 47 LUMIGAN, 74 LUNESTA, 38 LUPANETA, 49 LUPRON DEPOT, 21 Lutera, 46 LUZU, 68 LYNPARZA, 22 LYRICA, 37 LYSTEDA, 59 M MACROBID, 19 malathion, 71 MATULANE, 22 Matzim LA, 28 MAVIK, 23 MAXALT, 38 MAXALT-MLT, 38 medroxyprogesterone acetate, 52 medroxyprogesterone acetate 150 mg/mL, 49 mefloquine, 17 megestrol acetate susp, 52 megestrol acetate tabs 20 mg, 21 megestrol acetate tabs 40 mg, 21 MEKINIST, 21 meloxicam susp, 11 meloxicam tabs, 11 memantine, 32 MENEST, 49 MENOPUR, 50 MENOSTAR, 49 MENTAX, 68 meperidine soln, 13 meperidine tabs 100 mg, 13 meperidine tabs 50 mg, 12 MEPHYTON, 62 mercaptopurine, 20 METADATE CD, 37 METAGLIP, 42 metaxalone, 40 metformin, 41 metformin ext-rel tabs, 41 metformin ext-rel tabs 500 mg, 41 metformin ext-rel tabs 750 mg, 41 methimazole tabs 10 mg, 52 methimazole tabs 5 mg, 52 methocarbamol, 39 methotrexate oral, 61 methoxsalen oral, 69 methyldopa tabs 250 mg, 30 methyldopa tabs 500 mg, 30 METHYLIN, 37 methylphenidate, 36 methylphenidate ext-rel, 36 methylprednisolone, 51 metoclopramide, 53 metolazone tabs 10 mg, 29 metolazone tabs 2.5 mg, 5 mg, 29 metoprolol succinate ext-rel, 27 metoprolol tartrate, 27 METROCREAM, 71 METROGEL, 71 metronidazole crm, gel, lotion, 70 metronidazole tabs 250 mg, 500 mg, 19 MEVACOR, 26 MIACALCIN, 46 MICARDIS, 24 MICARDIS HCT, 24 Microgestin 1.5/30, 47 Microgestin 1/20, 46 Microgestin Fe 1.5/30, 47 Microgestin Fe 1/20, 46 miglitol, 41 minocycline, 16 minocycline ext-rel, 16 MIRAPEX, 35 MIRAPEX ER, 35 MIRCERA, 59 MIRCETTE, 47 mirtazapine orally disintegrating tabs, 34 mirtazapine tabs 15 mg, 34 mirtazapine tabs 7.5 mg, 30 mg, 45 mg, 34 misoprostol, 55 MOBIC, 11 modafinil, 40 Moderiba tabs, 19 moexipril, 22 moexipril/hydrochlorothiazide, 23 mometasone crm, lotion, oint 0.1%, 69 mometasone spray, 65 MONOCLATE-P, 59 Mononessa, 47 MONONINE, 59 montelukast, 65 morphine sulfate ext-rel, 13 morphine sulfate soln 20 mg/5 mL, 12 morphine sulfate soln 20 mg/mL, 10 mg/5 mL, 13 morphine sulfate tabs, 13 MOVANTIK, 55 MOXATAG, 16 moxifloxacin, 15 MOZOBIL, 60 MS CONTIN, 13 mupirocin crm, 68 mupirocin oint, 68 MUSE, 57 MYALEPT, 53 mycophenolate mofetil, 61 mycophenolate sodium delayed-rel, 62 MYKIDZ IRON susp 15 mg/1.5 mL, 63 MYRBETRIQ, 57 N nabumetone, 11 nadolol, 27 naftifine, 68 NAFTIN, 68 NAMENDA, 32 NAMENDA XR, 32 NAPRELAN, 11 naproxen EC tabs 375 mg, 11 naproxen EC tabs 500 mg, 11 naproxen sodium ext-rel, 11 naproxen sodium tabs 275 mg, 11 naproxen sodium tabs 550 mg, 11 naproxen susp, 11 naproxen tabs, 11 naratriptan, 38 NARCAN NASAL SPRAY, 40 NASONEX, 65 NATAZIA, 48 nateglinide, 44 NATPARA, 46 NATROBA, 71 Necon 0.5/35, 47 Necon 1/35, 47 Necon 1/50, 47 Necon 7/7/7, 47 nefazodone, 34 neomycin sulfate tabs, 14 neomycin/polymyxin B/dexamethasone, 73 NESINA, 42 NEULASTA, 59 NEUPOGEN, 59 NEUPRO, 35 NEURONTIN, 31 nevirapine, 17 nevirapine ext-rel, 17 NEXAVAR, 21 NEXIUM, 56 Next Choice One Dose, 48 niacin ext-rel, 26 NIASPAN, 26 nicardipine, 27 nicotine polacrilex gum, 40 nicotine polacrilex lozenge, 40 nicotine transdermal, 40 NICOTROL INHALER, 40 NICOTROL NS, 40 nifedipine, 27 nifedipine ext-rel, 27 NINLARO, 22 nisoldipine ext-rel, 27 nitrofurantoin ext-rel, 19 nitrofurantoin macrocrystals, 19 nitroglycerin lingual spray, 29 nitroglycerin tabs, 29 NITROSTAT, 29 nizatidine, 54 NORDITROPIN, 51 norethindrone acetate, 52 norethindrone/ethinyl estradiol 0.5 mg/2.5 mcg, 50 NORITATE, 71 Nortrel 0.5/35, 47 Nortrel 1/35, 47 Nortrel 7/7/7, 48 nortriptyline caps, 34 nortriptyline soln, 34 NORVASC, 27 NORVIR, 18 NOVOEIGHT, 59 NOVOFINE 30, 32 AUTOCOVER, 44 NOVOLIN 70/30, 43 NOVOLIN N, 43 NOVOLIN R, 43 NOVOLOG, 43 NOVOLOG MIX 70/30, 43 NOVOSEVEN RT, 59 NUCYNTA, 13 NUCYNTA ER, 13 NUTROPIN AQ, 51 NUVARING, 49 NUVIGIL, 40 NUWIQ, 59 nystatin, 16, 68 nystatin/triamcinolone, 68 O Ocella, 47 octreotide, 53 ODEFSEY, 17 ODOMZO, 22 OFEV, 66 ofloxacin, 15, 72 ofloxacin otic, 74 olanzapine, 35 olanzapine orally disintegrating tabs, 35 olanzapine/fluoxetine, 35 OLEPTRO, 34 olopatadine, 65, 72 omega-3 acid ethyl esters, 26 omeprazole delayed-rel caps 10 mg, 40 mg, 55 omeprazole delayed-rel caps 20 mg, 55 omeprazole/sodium bicarbonate, 55 OMNARIS, 66 OMNITROPE, 51 ondansetron orally disintegrating tabs 4 mg, 53 ondansetron orally disintegrating tabs 8 mg, 53 ondansetron tabs, soln, 53 ONETOUCH, 44 ONGLYZA, 42 OPANA, 13 OPANA ER, 13 OPSUMIT, 29 ORACEA, 71 ORENCIA 125 mg/mL, 60 ORENITRAM, 30 ORFADIN, 53 ORKAMBI, 65 orphenadrine ext-rel, 40 ORTHO TRI-CYCLEN, 48 ORTHO TRI-CYCLEN LO, 48 ORTHO-CYCLEN, 47 ORTHO-NOVUM 1/35, 47 ORTHO-NOVUM 7/7/7, 48 OSENI, 42 OSPHENA, 52 OTEZLA, 61 OTREXUP, 61 OVIDREL, 50 oxaprozin, 11 oxcarbazepine, 31 oxiconazole, 68 OXISTAT, 68 oxybutynin ext-rel, 57 oxybutynin syrup, 57 oxybutynin tabs, 57 oxycodone, 13 oxycodone/acetaminophen tabs, 13 oxycodone/aspirin, 13 oxycodone/ibuprofen, 13 OXYCONTIN, 13 oxymorphone, 13 P paliperidone ext-rel, 35 pantoprazole delayed-rel, 55 paricalcitol, 51 paroxetine, 33 paroxetine HCl ext-rel, 33 PATANASE, 65 PATANOL, 72 PAXIL, 33 PAXIL CR, 33 peg 3350/electrolytes, 55 PEGASYS, 61 PEGINTRON, 61 PEGINTRON REDIPEN, 61 penicillin VK, 16 PENLAC, 68 PENNSAID, 11 PENTASA, 54 pentoxifylline ext-rel, 60 perindopril, 22 permethrin, 71 PEXEVA, 33 phenazopyridine, 58 phenobarbital elixir, 31 phenobarbital tabs 15 mg, 16.2 mg, 32.4 mg, 64.8 mg, 97.2 mg, 100 mg, 31 phenobarbital tabs 30 mg, 60 mg, 31 PHENYTEK, 31 phenytoin, 31 phenytoin sodium, 31 phenytoin sodium extended, 31 PHOSLO, 52 pilocarpine, 74 pioglitazone, 43 pioglitazone/glimepiride, 44 pioglitazone/metformin, 43 piroxicam, 11 PLAVIX, 60 podofilox, 71 polymyxin B/trimethoprim, 72 POMALYST, 21 potassium chloride effervescent tabs 25 mEq, 62 potassium chloride oral liq 10%, 20%, 62 POTIGA, 31 PRADAXA, 58 PRALUENT, 26 pramipexole, 35 pramipexole ext-rel, 35 PRAMOSONE, 69 PRANDIN, 44 PRAVACHOL, 26 pravastatin, 26 prazosin 1 mg, 23 prazosin 2 mg, 5 mg, 24 PRECISION PCX, 45 PRECISION PCX PLUS, 45 PRECISION Q-I-D, 45 PRECISION SOF-TACT, 45 PRECISION XTRA, 45 PRECOSE, 41 prednisolone, 51 prednisolone acetate, 73 prednisolone sodium phosphate soln 15 mg/5 mL, 51 prednisolone sodium phosphate soln 5 mg/5 mL, 25 mg/5 mL, 51 prednisone dose pack 10 mg, 51 prednisone dose pack 5 mg, 51 prednisone soln, 51 prednisone tabs, 51 PREFEST, 50 PREMARIN, 49 PREMARIN crm, 50 PREMPHASE, 50 PREMPRO, 50 Prenatabs FA, 62 Prenatal Plus, 62 PRENATE ELITE, 62 PRESTALIA, 23 PREVACID, 56 PREVIDENT, 72 Previfem, 47 PREVPAC, 56 PREZCOBIX, 17 PREZISTA, 18 PRILOSEC, 56 PRILOSEC susp, 56 primidone, 31 PRISTIQ, 34 PROAIR HFA, 64 probenecid, 12 PROCENTRA, 37 prochlorperazine, 53 PROCRIT, 59 PROCYSBI, 53 PROFILNINE SD, 59 progesterone, micronized, 52 PROMACTA, 60 promethazine/phenylephrine, 64 PROMETRIUM, 52 propafenone, 25 propranolol ext-rel, 27 propranolol soln, 27 propranolol tabs 10 mg, 20 mg, 40 mg, 80 mg, 27 propranolol tabs 60 mg, 27 propylthiouracil, 52 PROSCAR, 56 PROTONIX, 56 PROTOPIC, 70 protriptyline, 34 PROVENTIL HFA, 64 PROVIGIL, 40 PROZAC, 33 PROZAC WEEKLY, 33 PRUMYX, 71 PULMICORT FLEXHALER, 66 PULMICORT RESPULES, 66 PULMOZYME, 65 Q QNASL, 66 QSYMIA, 45 Quasense, 48 quetiapine, 35 quinapril, 22 quinapril/hydrochlorothiazide, 23 quinidine gluconate, 25 quinidine sulfate tabs, 25 QVAR, 66 R rabeprazole delayed-rel, 55 raloxifene, 52 ramipril, 22 RANEXA, 30 ranitidine caps, syrup, 54 ranitidine tabs 300 mg, 54 RAPAFLO, 56 RAVICTI, 53 RAZADYNE, 32 RAZADYNE ER, 32 REBETOL, 19 REBIF, 39 RECOMBINATE, 59 RELENZA, 19 RELION products, 43 RELISTOR, 55 RELPAX, 38 REMODULIN, 30 RENAGEL, 52 RENVELA, 52 repaglinide, 44 repaglinide/metformin, 44 REPATHA, 26 REPRONEX, 50 REQUIP, 35 REQUIP XL, 35 RESCRIPTOR, 17 RESTASIS, 74 RETIN-A MICRO, 67 REVATIO susp, 30 REVATIO tabs, 30 REVLIMID, 21 REXAPHENAC, 12 REXULTI, 36 REYATAZ, 18 Ribapak, 19 Ribasphere, 19 ribavirin, 19 rifampin, 18 RIOMET, 42 risedronate, 46 risedronate delayed-rel, 46 RISPERDAL, 36 RISPERDAL M-TABS, 36 risperidone orally disintegrating tabs, 35 risperidone tabs 0.25 mg, 0.5 mg, 2 mg, 3 mg, 4 mg, 35 risperidone tabs 1 mg, 35 RITALIN LA, 37 rivastigmine, 32 rizatriptan, 38 rizatriptan orally disintegrating tabs, 38 ropinirole, 35 ropinirole ext-rel, 35 rosuvastatin, 26 ROZEREM, 38 S SABRIL, 32 SAIZEN, 51 SALKERA, 71 SAMSCA, 53 SANCUSO, 54 SANDOSTATIN, 53 SANDOSTATIN LAR, 53 SAPHRIS, 36 SARAFEM, 33 SAVAYSA, 58 SAVELLA, 37 SAXENDA, 45 SEASONIQUE, 48 selenium sulfide lotion, shampoo 2.5%, 69 SELZENTRY, 17 SENSIPAR, 45 SEREVENT, 65 SEROQUEL, 36 SEROQUEL XR, 36 SEROSTIM, 51 sertraline oral concentrate, 33 sertraline tabs, 33 SIGNIFOR, 53 sildenafil tabs 20 mg, 29 silver sulfadiazine, 68 SIMPONI, 61 simvastatin, 26 SINGULAIR, 65 sirolimus, 62 SIRTURO, 18 SIVEXTRO, 19 SKELAXIN, 40 sodium fluoride 0.5 mg (1.1 mg) tabs, 71 sodium fluoride 1 mg (2.2 mg) tabs, 71 sodium fluoride chew tabs, 71 sodium fluoride paste 1.1%, 71 sodium fluoride soln 0.125 mg/drop F (from 0.275 mg/drop NaF), 71 sodium fluoride soln 0.25 mg/drop F (from 0.55 mg/drop NaF), 0.5 mg/mL F (from 1.1 mg/mL NaF), 71 sodium fluoride/potassium nitrate paste 1.1-5%, 71 SOFT TOUCH, 44 SOFTCLIX, 45 SOLODYN, 16 SOMATULINE, 53 SOMAVERT, 53 SONATA, 38 SOOLANTRA, 70 sotalol tabs 120 mg, 240 mg, 25 sotalol tabs 80 mg, 160 mg, 25 SOVALDI, 19 SPECTRACEF, 15 spinosad, 71 SPIRIVA, 63 spironolactone tabs 25 mg, 23 spironolactone tabs 50 mg, 100 mg, 23 spironolactone/hydrochlorothiazide, 29 SPORANOX, 17 Sprintec, 47 SPRYCEL, 21 STALEVO, 35 STARLIX, 44 stavudine, 18 STAVZOR, 32 STAXYN, 57 STELARA, 69 STIMATE, 53 STIVARGA, 21 STRATTERA, 37 STRENSIQ, 53 STRIBILD, 17 SUBOXONE FILM, 40 SUBSYS, 13 sucralfate, 56 SULAR, 28 sulfacetamide oint 10%, 72 sulfacetamide sodium, 67 sulfacetamide soln 10%, 72 sulfamethoxazole/trimethoprim susp, 16 sulfamethoxazole/trimethoprim tabs, 16 sulfasalazine, 54 sulindac tabs 150 mg, 11 sulindac tabs 200 mg, 11 sumatriptan, 38 SUMAVEL DOSEPRO, 38 SUPRAX, 15 SURESTEP, 45 SUSTIVA, 17 SUTENT, 21 SYLATRON, 61 SYMBICORT, 66 SYMBYAX, 36 SYMLINPEN, 41 SYNAREL, 49 SYNERA, 70 SYNTHROID, 53 T TACLONEX, 69 tacrolimus, 62, 70 TAFINLAR, 21 TAGRISSO, 21 TAMIFLU, 19 tamoxifen, 20 tamsulosin, 56 TANZEUM, 43 TARCEVA, 21 TARGRETIN caps, 22 TARGRETIN gel, 22 TARKA, 23 TASIGNA, 21 TAZORAC, 67 TECFIDERA, 39 TEGRETOL-XR, 32 TEKTURNA, 28 TEKTURNA HCT, 28 telmisartan, 24 telmisartan/amlodipine, 24 telmisartan/hydrochlorothiazide, 24 temazepam caps 15 mg, 30 mg, 37 temazepam caps 7.5 mg, 22.5 mg, 37 TEMODAR, 20 temozolomide, 20 terazosin, 24 terbinafine, 16 TESTIM, 41 testosterone cypionate, 41 testosterone enanthate, 41 testosterone gel, 41 testosterone gel pump 1%, 41 tetrabenazine, 37 tetracycline caps 250 mg, 16 tetracycline caps 500 mg, 16 THALOMID, 21 theophylline, 67 theophylline ext-rel 12hr tabs 100 mg, 67 thioridazine tabs 10 mg, 25 mg, 100 mg, 36 thioridazine tabs 50 mg, 36 thyroid tabs, 52 tiagabine, 31 TIKOSYN, 25 timolol maleate gel, 73 timolol maleate soln, 73 TIVICAY, 17 tizanidine, 40 TOBI, 65 TOBRADEX oint, 73 TOBRADEX susp, 73 tobramycin, 72 tobramycin inhalation soln, 65 tobramycin/dexamethasone susp 0.3%/0.1%, 73 tolterodine, 57 tolterodine ext-rel, 57 TOPAMAX, 32 topiramate sprinkle caps, 31 topiramate tabs 25 mg, 31 topiramate tabs 50 mg, 100 mg, 200 mg, 31 TOPROL-XL, 27 torsemide tabs 20 mg, 100 mg, 28 torsemide tabs 5 mg, 10 mg, 28 TOUJEO, 43 TOVIAZ, 58 TRACLEER, 29 TRADJENTA, 42 tramadol, 12 tramadol ext-rel, 13 tramadol/acetaminophen, 13 trandolapril, 22 trandolapril/verapamil ext-rel, 23 tranexamic acid, 59 TRAVATAN Z, 74 travoprost, 74 trazodone tabs 300 mg, 34 trazodone tabs 50 mg, 100 mg, 150 mg, 34 TRESIBA, 43 tretinoin, 67 tretinoin gel microsphere, 67 TRETIN-X, 67 TREXIMET, 39 triamcinolone acetonide crm 0.5%, 70 triamcinolone acetonide crm, oint 0.1%, 0.025%, 69 triamcinolone acetonide crm, oint 0.5%, 69 triamcinolone acetonide lotion, 69 triamterene/hydrochlorothiazide, 29 triazolam, 38 TRIBENZOR, 25 TRICOR, 25 TRILEPTAL, 32 TRILIPIX, 25 Tri-Lo Sprintec, 48 trimethobenzamide, 53 trimethoprim, 19 Trinessa, 48 TRI-NORINYL, 48 Tri-Previfem, 48 Tri-Sprintec, 48 TRIUMEQ, 17 Trivora, 48 TRIZIVIR, 17 trospium, 57 trospium ext-rel, 57 TRULICITY, 42 TRUSOPT, 73 TRUVADA, 17 TUDORZA, 63 TUSSIONEX, 64 TYKERB, 21 TYVASO, 30 TYZEKA, 19 U ULORIC, 12 ULTRACET, 13 ULTRAM, 13 ULTRAM ER, 13 UPTRAVI, 30 UROXATRAL, 57 URSO, 54 URSO FORTE, 54 ursodiol, 54 V VAGIFEM, 50 valacyclovir, 19 VALCHLOR, 20 VALCYTE, 18 valganciclovir, 18 valproic acid, 31 valsartan, 24 valsartan/hydrochlorothiazide, 24 VALTREX, 19 VANCOCIN, 20 vancomycin, 19 VARUBI, 54 VASCEPA, 26 VCF VAGINAL CONTRACEPTIVE FOAM, 49 VECTICAL, 69 Velivet, 48 VELTASSA, 62 venlafaxine, 33 venlafaxine ext-rel, 33 VENTAVIS, 30 VENTOLIN HFA, 64 VERAMYST, 66 verapamil, 28 verapamil ext-rel, 28 VERELAN PM, 28 VESICARE, 57 VEXOL, 73 VFEND, 17 VIAGRA, 57 VIBERZI, 55 VICTOZA, 42 VIDEX soln, 18 VIGAMOX, 72 VIIBRYD, 33 VIMOVO, 11 VIMPAT, 32 VIRACEPT, 18 VIRAMUNE XR, 18 VIREAD, 18 VIVELLE-DOT, 49 VOGELXO, 41 voriconazole, 16 VOTRIENT, 21 VRAYLAR, 36 VYTORIN, 26 VYVANSE, 36 W warfarin, 58 Wee Care susp 15 mg/1.25 mL, 62 WELCHOL, 25 WELLBUTRIN, 34 WELLBUTRIN SR, 34 WELLBUTRIN XL, 34 WILATE, 59 X XALATAN, 74 XALKORI, 21 XARELTO, 58 XARTEMIS XR, 13 XELJANZ, 61 XELJANZ XR, 61 XELODA, 20 XENAZINE, 37 XENICAL, 45 XIFAXAN 550 mg, 20 XIGDUO XR, 44 XOPENEX, 64 XOPENEX HFA, 64 XTANDI, 20 Xulane, 49 XYNTHA, 59 XYZAL, 63 Y YASMIN, 47 YAZ, 46 Z zafirlukast, 65 zaleplon, 38 ZARXIO, 59 ZEGERID, 56 ZELBORAF, 21 ZETIA, 25 ZETONNA, 66 ZIAGEN soln 20 mg/mL, 18 zidovudine, 18 ZIOPTAN, 74 ziprasidone, 35 ZIPSOR, 11 ZITHROMAX, 15 ZMAX, 15 ZOCOR, 26 ZOFRAN, 54 ZOHYDRO ER, 13 ZOLINZA, 22 zolmitriptan, 38 zolmitriptan orally disintegrating tabs, 38 ZOLOFT, 33 zolpidem, 38 zolpidem ext-rel, 38 zolpidem sublingual, 38 ZOLPIMIST, 38 ZOMACTON, 51 ZOMIG, 39 ZOMIG-ZMT, 39 ZONEGRAN, 32 zonisamide, 31 ZONTIVITY, 60 ZORBTIVE, 51 ZORTRESS, 62 ZORVOLEX, 11 Zovia 1/35e, 47 ZOVIRAX crm, 71 ZOVIRAX oint, 71 ZUPLENZ, 54 ZYDELIG, 21 ZYFLO CR, 65 ZYKADIA, 21 ZYLET, 73 ZYPREXA, 36 ZYPREXA ZYDIS, 36 ZYTIGA, 20 ZYVOX, 20 Pharmacy Services Capital BlueCross P&T Committee P.O. Box 773735 Harrisburg, PA 17177-3735 2016 Capital BlueCross Formulary
Similar documents
Blue Cross and BCN Custom Drug List - July 2016
The Blue Cross and BCN Preferred Alternatives — July 2016 list represents possible alternatives to nonpreferred drugs. These alternative medications can generally be prescribed without approval fro...
More information